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Abstract 
 
Sexual differentiation is a fundamental characteristic of all eukaryotes, dictating sex-
specific morphology, physiology and behavior. Diploid organisms with heteromorphic sex 
chromosomes (XX or XY) require regulatory compensation of the X chromosome to maintain 
correct levels of genetic expression between the sexes, a process termed sex-specific dosage 
compensation (SSDC). The fruit fly, Drosophila melanogaster dosage compensates by 
upregulating transcription of most X-linked genes two-fold. Associated with this two-fold up 
regulation is the male-specific lethal (MSL) complex, a RNA-protein complex comprised of at 
least five known proteins; MSL1, MSL2, MSL3, males absent on the first (MOF), and maleless 
(MLE) and two non-translated RNA molecules; roX1 (RNA on the X chromosome) and roX2. 
The complex modulates the chromatin structure of the male X chromosome via acetylation of 
H4K16. MOF and MSL3 both exhibit an N-terminal chromodomain, whose function is unclear.  
The MSL3 chromodomain has been suggested to bind H3K36Me3. Chromodomains are a 
paradigm of how a single structural fold has evolved in diverse proteins to bind distinct targets. 
Chromodomains are common to nuclear regulators, and bind diverse targets including histones, 
DNA, and RNA. They function as recognition motifs of histone post-translational modifications 
and facilitate the translation of the histone code into a distinct local chromatin structure via 
recruiting the appropriate chromatin modulating machinery. 
The goal of this research is to determine the structure of the D. melanogaster MOF and 
MSL3 chromodomains by X-ray crystallographic and/or nuclear magnetic resonance 
techniques, to advance our understanding of the structural characteristics of these diverse 
domains. Here we report the cloning and reproducible expression and purification of the D. 
melanogaster MOF and MSL3 chromodomains and their Homo sapiens orthologues. The D. 
melanogaster MOF chromodomain, whose NMR structure was published during this research, 
has been crystallized. Attempts to solve the crystal structure by molecular replacement, 
multiple-wavelength anomalous dispersion, and single-wavelength isomorphous replacement 
are reported. 
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1.0  Literature Review 
 
1.1  Introduction 
Epigenetic regulation in biology refers to the regulation of gene expression by a 
mechanism that does not directly alter the genetic code. Epigenetic regulation involves DNA 
methylation, chromatin remodeling and post-translational modification of histone tails. Dosage 
compensation, the equalization of X-linked gene expression between males and females is a 
paradigm of epigenetic regulation. The fruit fly, Drosophila melanogaster dosage compensates 
by up-regulating transcription of most male X-linked genes two-fold. Associated with this two-
fold up regulation is the male-specific lethal (MSL) complex, a RNA-protein complex 
comprised of at least five known proteins; MSL1, MSL2, MSL3, males absent on the first 
(MOF), and maleless (MLE) and two non-translated RNA molecules; roX1 (RNA on the X 
chromosome) and roX2. The MSL protein-RNA complex modulates the chromatin structure of 
the male X chromosome, presumably via acetylation of K16 of histone H4. MOF and MSL3 
both exhibit an N-terminal chromodomain. Numerous chromatin modification complexes 
exhibit chromodomains, where they function as a recognition module of histone post-
translational modifications, facilitating chromatin interactions. 
This research aims to structurally characterize the MSL3 and MOF chromodomains of 
the D. melanogaster dosage compensation complex, and their human orthologues. Structural 
investigation will include X-ray crystallographic and NMR techniques, which will involve 
crystallizing and isotopically labeling of the recombinant proteins, respectively. Solution of the 
structures will advance our understanding of the structural characteristics of these diverse 
domains. The following literature review places this research in context, and will focus 
specifically on epigenetic regulation and how it pertains to dosage compensation in D. 
melanogaster. The literature review will begin with a discussion of sexual differentiation and 
determination, and how this dictates dosage compensation. This is followed by the introduction 
of chromatin structure and how epigenetic regulation, and ultimately dosage compensation 
arises via chromatin post-translational modification, remodeling, and histone variation. This 
sets the stage for the introduction of the D. melanogaster dosage compensation complex, its 
components and mechanism. The structure and function of chromodomains is then summarized, 
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with specific focus on the MOF and MSL3 chromodomains of the D. melanogaster dosage 
compensation complex. 
 
1.2  Sex 
Sexual differentiation is a fundamental characteristic of higher eukaryotes, dictating 
sex-specific morphology, physiology and behavior. Interestingly, the mechanism of sexual 
differentiation between organisms is not widely conserved. A number of different genetic and 
epigenetic systems have evolved to generate sexual dimorphism. Diploid organisms with 
heteromorphic sex chromosomes (XX or XY) require regulatory compensation of the X 
chromosome to maintain correct levels of genetic expression between the sexes, a process 
termed sex-specific dosage compensation (SSDC). The heteromorphic sex chromosomes (ZZ or 
ZW) of birds, reptiles and fish do not exhibit sex specific dosage compensation, rather dosage 
compensation occurs via a distinct mechanism known as network dosage compensation (NDC) 
(Arnold et al., 2008). NDC operates on all chromosomes, and is associated with the coordinate 
expression of a network of associated genes (Arnold et al., 2008). 
Like the evolution of sexual differentiation, the mechanisms of dosage compensation 
between organisms are diverse. Female humans (Homo sapiens) and female fruit flies (D. 
melanogaster) have two X chromosomes, whereas the males have an X and a Y chromosome. 
The Y chromosome has evolved largely from degenerative processes, is gene-poor, and 
heterochromatic. The Y chromosome plays no role is sex determination but is involved in 
fertility (Larsson and Meller, 2006). The Y chromosome of the nematode worm Caenorhabditis 
elegans has been lost altogether. The hermaphrodites exhibit a XX genotype, whereas the males 
are XO (Lucchesi et al., 2005). All three organisms exhibit different dosage compensation 
mechanisms though they achieve the same goal, equalization of X-linked gene product between 
the two sexes. D. melanogaster males overcome their haploinsufficiency (requirement for both 
alleles of a gene for fitness) by transcriptionally upregulating expression of the single X 
chromosome roughly two-fold to equal that of the diploid females (Lucchesi, 1973). No 
universal two-fold upregulation exists, rather individual genes are compensated to a level that 
ensures fitness (Hamada et al., 2005; Straub et al., 2005). In humans the females inactivate 
large regions of one of their X chromosomes, forming a Barr body, to compensate for the males 
single X chromosome (Lyon, 1961). In C. elegans the hermaphrodite downregulates both of its 
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X chromosomes to compensate for the males single X chromosome (Meyer and Casson, 1986). 
The DC mechanism of humans and C. elegans results in males and females being effectively 
monosomic for the X chromosome relative to the diploid autosomes and therefore 
haploinsufficient. Global gene expression profiles indicate that humans and C. elegans 
compensate for this independently by transcriptionally upregulating the X chromosome 
expression roughly two-fold (Gupta et al., 2006; Nguyen and Disteche, 2006) (Figure 1.1). The 
evolution of the respective DC mechanisms is distinct but they share an underlying paradigm, 
the modulation of transcription via the formation of transcriptionally permissive or repressive 
chromatin states. DC is therefore an epigenetic process, a process that alters an organism’s         
genetic expression profile without altering the genetic code of that organism. 
 
 
 
 
 
 
Figure 1.1: Dosage compensation mechanisms. D. melanogaster males transcriptionally 
upregulate their single X chromosome. Female H. sapiens inactivate one of their X 
chromosomes. C. elegans hermaphrodites transcriptionally downregulate both X chromosomes. 
X chromosome expression in H. sapiens and C. elegans is transcriptionally upregulated to equal 
that of the diploid autosomes. Activation is represented by green, inactivation by red. Figure 
reproduced from (Straub and Becker, 2007). 
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1.3  Sex Determination and Dosage Compensation in D. melanogaster 
The commitment to a sexual phenotype in any organism begins with a primary signal, 
which can be environmental or genetic. The primary signal, which differs between sexes 
initiates a signaling cascade that alters genetic expression in a sex-dependent manner leading to 
a sexual phenotype. In D. melanogaster the sex determination primary signal is the X 
chromosome to autosome ratio (X:A). Females have a X:A ratio of 1 (2X:2A) whereas males 
have a ratio of 0.5 (X:2A). 
The X:A ratio is read by the basic helix-loop-helix protein product of the X-linked 
sisterlessB (sisB) gene. In females only, zygotically expressed sisB and maternal daughterless 
(da) proteins form heteromeric complexes that bind to the early promoter of the sex-lethal (sxl) 
gene and control its all-or-nothing expression (Yang et al., 2001). Sxl encodes an RNA binding 
protein that functions in sex-specific alternative splicing pathways. The female X:A ratio of 1 is 
transduced into the transcriptional activation of early sxl. The male X:A ratio of 0.5 is 
transduced into the transcriptional repression of early sxl. Sxl and its downstream cascade 
control sexual differentiation of the soma, germline development, and dosage compensation. 
This occurs early on in embryogenesis around the blastoderm stage and is irreversible. After the 
blastoderm stage Sxl controls its own expression via a positive autoregulatory loop involving an 
alternative splicing pathway. After the blastoderm stage sxl is activated by the late promoter 
and is expressed in both sexes. The absence of early Sxl protein in males results in the inclusion 
of exon L3 in the sxl mRNA, which contains a stop codon. Late Sxl protein in males is therefore 
truncated and nonfunctional. In females early Sxl protein is involved in the alternative splicing 
of late sxl mRNA, splicing out exon L3. This produces a transcript with the complete open 
reading frame, which is translated to produce active Sxl protein (Cline, 1993).  
The transformer (tra) gene is downstream of sxl and is expressed in both males and 
females. Intron 1 of tra has a proximal and a distal 3’ splice site. In the absence of Sxl protein 
the proximal 3’ splice site is used, which introduces a stop codon. The inclusion of this stop 
codon produces a truncated, nonfunctional Tra protein. In females the presence of Sxl protein 
dictates the use of the distal 3’ splice site. The stop codon is no longer introduced and active 
Tra protein is produced. Tra forms a heterodimer with Transformer2 (Tra2) protein, which 
controls the sex-specific splicing of the doublesex (dsx) and fruitless (fru) genes (Bopp et al., 
1999). The female splice-specific products FruF and DsxF control the expression of genes 
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necessary for female differentiation and behavior. In males the absence of Tra results in the 
male splice-specific products FruM and DsxM, which control the expression of genes necessary 
for male differentiation and behavior (Figure 1.2). 
Sxl is the key determinant in sexual determination and dosage compensation, controlling 
each via a sex-specific alternative-splicing pathway. Dosage compensation in D. melanogaster 
involves the transcriptional upregulation of the male single X chromosome approximately two-
fold. This upregulation is achieved via an epigenetic process that alters the chromatin structure, 
presumably increasing the accessibility of transcriptional factors or alternatively facilitating the 
 
 
 
 
 
 
Figure 1.2: Sexual determination and dosage compensation in D. melanogaster. At the 
blastoderm stage of embryogenesis the X:A ratio dictates the all-or-nothing expression of Sxl. 
A X:A of 1 activates Sxl expression leading to the development of a female phenotype and 
inactive dosage compensation. A X:A ratio of 0.5 represses Sxl expression leading to a male 
phenotype and active dosage compensation. The solid line represents the female pathway, the 
dotted line the male pathway. Based on Figure 1 and Figure 2 from (Penalva and Sanchez, 
2003). 
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elongation process. This altered, decondensed chromatin structure is associated with painting of 
the male X chromosome with a non-translated RNA and sex-specific global acetylation of 
lysine 16 of histone 4 (H4K16Ac). Associated with the male specific X chromosome 
modifications are five male-specific lethal (msl) genes: msl1, msl2, msl3, males-absent-on-the-
first (mof), and maleless (mle), and two non-coding RNA molecules: RNA-on-the-X 1 (roX1) 
and roX2 (Stuckenholz et al., 1999). The protein products of these genes form a protein-RNA 
complex, the dosage compensation complex (DCC) that associates specifically with the male X 
chromosome. The role that the complex plays in dosage compensation in males will be 
discussed in greater detail in section 1.5. The msl and roX genes are transcribed in both males 
and females however Sxl turns off dosage compensation in females by controlling msl2 
expression. Sxl represses msl2 mRNA expression in females by binding to a poly(U) stretch in 
the 5’UTR, preventing splicing of the first intron. At a later stage, binding of Sxl to the poly(U) 
stretches at the 5’ and 3’ UTRs prevents translation of the msl2 mRNA (Bashaw and Baker, 
1995). The absence of MSL2 protein in females prevents formation of a functional complex as 
MSL2 is integral to complex formation and hence dosage compensation does not occur. If the 
msl2 cDNA is ectopically expressed from a plasmid a functional DCC forms in females (Chang 
and Kuroda, 1998). 
 
 
1.4  Chromatin Structure 
In D. melanogaster, dosage compensation involves the modulation of transcription via 
the altering of the local chromatin structure. Chromatin is a hierarchical structure of histone 
proteins that compacts the meters of DNA found in a eukaryotic nucleus. The functional 
repeating unit of chromatin is the nucleosome core particle (NCP). The D. melanogaster NCP 
comprises ~146bp of DNA wrapped around an octamer comprised of two H2A-H2B 
heterodimers and a (H3-H4) tetramer (Clapier et al., 2008). The ~146bp of DNA form 1.65 left-
handed superhelical turns around the histone octamer. In the yeast NCP structure histone N-
terminal tails are relatively disordered and solvent exposed, protruding out from the 
nucleosome core (White et al., 2001) (Figure 1.3). 
The nucleosomes are spaced along the linear DNA in a beads-on-a-string array (11nm 
fiber). The nucleosomes are separated by short stretches of unbound DNA, typically 10-50 bp 
long (Schwab et al., 2008). This string of nucleosomes can compact to from a higher ordered 
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30nm fiber, in which histone H1 contacts neighboring nucleosomes. The exact structure of the 
30nm fiber is a contentious issue. Two major models exist: the one-start solenoidal helix, which 
is a linear array of coiled nucleosomes with a bent DNA linker between adjacent nucleosomes 
and the two-start helix where nucleosomes zig-zag to form a ribbon that supercoils, with a 
straight DNA linker (Dorigo et al., 2004; Woodcock et al., 1984) (Figure 1.4). The crystal 
structure of a tetranucleosome exhibits adjacent nucleosomes linked by straight DNA, 
supporting the two-start hypothesis (Schalch et al., 2005; Wu et al., 2007). The hierarchical 
structure continues until the metaphase chromosome is achieved. 
 
 
 
 
 
 
 
 
Figure 1.3: Structure of the yeast Saccharomyces cerevisiae nucleosome core particle PDB 
1id3 (White et al., 2001). Histone H2A is shown in yellow, H2B in red, H3 in blue and H4 in 
green. DNA is shown in turquoise. Figure taken from http://en.wikipedia.org/wiki/Nucleosome, 
with permission from Richard Wheeler (Zephyris) at wikipedia.org). 
H2B N 
H3 N 
H4 N 
H2A N 
H2B N 
H3 N 
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                                         A.                                                B. 
 
Figure 1.4: Models of the 30 nm chromatin fiber. Two major models exist: the one-start 
solenoidal helix, which is a linear array of coiled nucleosomes (A), and the two-start helix 
where nucleosomes zig-zag to form a ribbon that supercoils (B) (Dorigo et al., 2004). 
 
 
 
Chromatin structure is highly dynamic and its local structure can impede or promote all 
essential DNA processes such as recombination, DNA repair, replication and transcription. The 
two major chromatin states found within the cell nucleus are heterochromatin and euchromatin. 
Heterochromatin’s condensed structure represses transcriptional activity. Heterochromatic 
regions include repetitive satellite sequences, centromeres, telomeres, and the inactive X 
chromosome (Barr body) of female mammals (Lohe et al., 1993). Heterochromatin can be 
either constitutive or facultative. Constitutive heterochromatin is defined as regions of 
heterochromatin identical in all cells of a species. The Y chromosome is largely constitutive 
heterochromatin. Facultative heterochromatic is defined as regions of heterochromatin that 
differ between cells of an organism. X chromosome inactivation in female mammals involves 
the formation of facultative heterochromatin (Craig, 2005). Unlike euchromatin, 
heterochromatin is only found in eukaryotes, not prokaryotes. Euchromatin has a diffuse, 
decondensed structure, which is transcriptionally permissive. Euchromatic regions are generally 
gene-rich and actively transcribed. Eukaryotic cells can control replication and the differential 
expression of a gene by transforming from heterochromatin to euchromatin. Elaborate 
mechanisms have evolved to modulate chromatin structure. Modulation of chromatin structure 
to facilitate either a transcriptionally repressive or permissive state hinges around changes in 
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nucleosome histone composition , ATP-dependent chromatin remodeling, and the reversible 
post-translational modification of the histone N-terminal tails, which protrude out from the 
NCP. Modulation of chromatin structure is quintessential to dosage compensation. 
 
1.4.1  Histone Variants 
The canonical nucleosome is composed of histones H2A, H2B, H3, and H4. Histone H1 
acts as a linker between nucleosomes. A number of variants are known for all histones, except 
H4. The function of the individual variants is diverse, ranging from transcriptional activation, 
recombination and repression to DNA repair. Histone variant incorporation modulates 
chromatin structure via altering intra- and inter-nucleosomal contacts and potential new targets 
for unique post-translational modifications. The role of histone post-translational modification 
is discussed in-depth in a later section (1.5.1). Unlike the canonical histones, which are encoded 
by multiple genes, a single gene encodes the various histone variants. Variant histone genes fall 
into one of three classes: replication dependent (RD), replication and cell-cycle independent 
(RI), and tissue specific (TS) based upon their expression. The dependence upon replication 
refers to whether or not the histone is deposited during DNA replication, behind the progressing 
replication fork. The nucleosome code theory defines the hypothesis that functionally distinct 
homotypic nucleosomes are formed by the specific incorporation of a distinct histone variant. 
The incorporation of different variants confers distinct functions (Bernstein and Hake, 2006). 
See Table 1.1 for a synopsis of histone variants, their class and function. 
Histone H1 expression is highly specific to tissue, species, and developmental stage. 
The H1 family is large and members are often redundant, functioning in chromatin 
condensation via forming contacts with neighboring nucleosomes. Binding of H1 and its 
variants to neighboring nucleosomes and the linker DNA between nucleosomes is transient 
(Lever et al., 2000). Deletion studies demonstrated that cells can exist without, or with 
drastically reduced levels of H1 and that deletion of one variant is compensated for by the 
increased expression of another variant (Fan et al., 2003; Takami et al., 2000; Wierzbicki and 
Jerzmanowski, 2005).  
Four major H2A variants are known H2A.X, H2A.Z, macroH2A, and H2ABbd (Barr 
body deficient). While H2A.X is the main form in the yeast S. cerevisiae, in mammals this 
histone functions as a DNA damage sensor. Phosphorylated H2A.X, denoted γ-H2A.X, is 
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enriched at double-strand break points (Redon et al., 2002). H2A.Z functions in gene silencing 
in mammals (Rangasamy et al., 2003). The D. melanogaster H2A.Z homologue, H2AvD plays 
an important role in, but is not specific to dosage compensation. H2AvD, is involved in gene 
activation and silencing (Zlatanova and Thakar, 2008). Ubiquitination of its C-terminal tail or 
acetylation of its N-terminal tail differentiates between silencing and activation, respectively 
(Sarcinella et al., 2007). In terms of dosage compensation in D. melanogaster, the histone 
variant H2AvD is incorporated into, and helps maintain euchromatic regions via acetylation of 
its N-terminal tail (Tanabe et al., 2008). In female mammals incorporation of the H2A variants 
macroH2A1.1 and macroH2A1.1, splice variants of H2A1 is essential to X inactivation, and 
ultimately dosage compensation (Chow and Brown, 2003). MacroH2A is vertebrate-specific 
and is very large. It is incorporated into chromatin of the inactive mammalian female X 
chromosome (Barr body), functioning in transcriptional repression (Costanzi and Pehrson, 
1998). As its name indicates H2A.Bbd is Barr body deficient. It is the most distantly related 
H2A variant and associates with regions of hyperacetylated H4, suggesting a role in 
transcriptional activation (Chadwick and Willard, 2001). Three H2B variants are known, all of 
which are testis/sperm specific. The function of human-sperm-specific H2B (spH2B), human 
testis/sperm-specific H2B (hTSH2B), and H2BFWT are not well characterized but 
nucleosomes containing these variants are less stable and may confer resistance to apoptosis 
(Cheung et al., 2003; Li et al., 2005a).  
To date five histone H3 variants have been described in mammals, H3.1, H3.2, H3.3, 
H3.1t and CENP-A. It is suggested that H3.1, H3.2, and H3.3 are incorporated into constitutive 
heterochromatin, facultative heterochromatin, and euchromatin respectively (Hake and Allis, 
2006). In D. melanogaster the histone H3.3 variant plays an important role in, but is not 
specific to dosage compensation. Absent from heterochromatin, H3.3 is enriched in 
euchromatin of the male X chromosome, throughout all active genes (Wirbelauer et al., 2005). 
H3.3 deposition is linked to RNA polymerase II activity and correlates with dimethylated H3 
K4, an epigenetic mark associated with transcriptionally active chromatin (Mito et al., 2005). 
H3.1t is a testis specific variant (Witt et al., 1996). The H3 variant CENP-A is a critical 
centromeric protein, localized exclusively to the active kinetochore (Sullivan, 2001). 
While the nature of DNA-packaging into discreet nucleosomes and the organization of 
said nucleosomes into higher ordered structures is highly conserved, the authors of an
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Table 1.1: H2A, H2B, and H3 variants. Synopsis of histone H2A, H2B, and H3 variant 
expression, chromosomal localization, replication dependence (RD or RI) and function. In D. 
melanogaster (D. m), the histone variant H2AvD is involved in dosage compensation via 
maintain euchromatic regions via acetylation of its N-terminal tail (Tanabe et al., 2008). 
 
 
    
Histone variant Expression Localization Function 
    
H2AX RI All DNA repair 
H2A.Z RI All Activation and silencing 
H2Av (D. m) RI All 
   
Activation and silencing 
(Dosage Compensation) 
H2A.Bdb unknown not Inactive X Activation 
MacroH2A unknown Inactive X Inactivation 
    
spH2B unknown Telomeres Unknown 
hTSH2B unknown unknown Unknown 
H2BFWT unknown Telomeres Unknown 
    
H3.1 RD Constitutive H Inactivation 
H3.2 RD Facultative H Inactivation 
H3.3 RI Euchromatin 
   
Activation 
(Dosage Compensation) 
H3.1t RD unknown Unknown 
CENP-A RI Centromeres Segregation 
    
 
 
 
 
 
exhaustive review of histone variants suggest that the site-specific incorporation of histone 
variants exists to maintain dynamic regulation of chromatin structure through altered 
nucleosome structure and distinct post-translational modifications specific to the respective 
histone variant (Bernstein and Hake, 2006). 
 
1.5  Dosage Compensation in D. melanogaster 
In D. melanogaster, associated with the two-fold up regulation of transcription is the 
male-specific lethal (MSL) complex, a RNA-protein complex comprised of at least five known 
proteins; MSL1, MSL2, MSL3, MOF, and MLE and two non-translated RNA molecules; roX1 
(RNA on the X chromosome) and roX2 that directly modulates the chromatin structure of the 
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male X chromosome (Lucchesi, 1998; Straub and Becker, 2007). MOF and MLE have 
enzymatic activity. MLE is a DExH box /DNA helicase with ATPase activity (Lee et al., 1997). 
MOF is a MYST (MOZ, YBF2/SAS3, SAS2, Tip60) family histone acetyl transferase (HAT) 
(Akhtar and Becker, 2000). MYST family HATs are characterized by a unique C2HC zinc 
finger and a N-terminal chromodomain. The MYST family is one of three distinct groups of Nε-
lysine acetyltransferases, the other groups are Gcn5/PCAF and p300/CBP (Yang, 2004). A 
model for the assembly of the dosage compensation complex on the male X chromosome is 
shown in Figure 1.5. 
 
1.5.1  Histone Post-translational Modification and Dosage Compensation 
Histones are subject to many types of reversible post-translational modifications, 
including methylation (mono-, di-, or tri-), phosphorylation, ubiquitination, acetylation, 
sumoylation, ADP-ribosylation, and biotinylation (Peterson and Laniel, 2004). These 
modifications are typically localized to lysine (K), arginine (R), threonine (T), serine (S), 
glutamic acid (E), histidine (H), and tyrosine (Y) residues in the histone N-terminal tail, which 
protrude from the nucleosome core particle. Histone C-terminal tails are also capable of being 
post-translationally modified, but they are not as common or as intrinsic to epigenetic 
regulation as post-translational modifications of the histone N-terminal tails (Fingerman et al., 
2007). All four histone N-terminal tails are highly post-translationally modified. It is likely that 
the conformation of the histone N-terminal tails is highly flexible, and that contacts between the 
histone tails and DNA is transient. Histone post-translational modification is thought to 
function through directly altering intra- and inter-nucleosomal interactions (cis acting) and/or 
by creating docking sites for effecter molecules (trans acting). It is proposed that the distinct 
modifications of one or more histone tails can act sequentially or in concert to initiate a distinct 
chromatin modulating cascade, a theory defined as the histone code hypothesis (Strahl and 
Allis, 2000). 
Histone acetylation is a post-translational modification intrinsic to transcriptional 
regulation in eukaryotes. Histone acetylation is predominantly associated with upregulation, 
however a repressive function has also been demonstrated in D. melanogaster and yeast 
(Grienenberger et al., 2002). Histone acetylation alters nucleosome-DNA and nucleosome-
nucleosome interactions (cis-acting) (Hong et al., 1993; Luger et al., 1997) and acetylated 
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histones are directly bound by bromodomains (trans-acting) (Dhalluin et al., 1999). The 
incorporation of H4 homogenously acetylated at K16 into nucleosomal arrays prevents 
formation of the 30 nm fiber and inter-fiber contacts in vivo, suggesting that the modification 
may in part be cis-acting (Shogren-Knaak et al., 2006). H4K16 has been proposed to interact 
with an acidic residue rich patch on the surface of the H2A-H2B dimer of a neighboring 
nucleosome (Luger et al., 1997). Acetylation of H4K16 would therefore presumably disrupt 
this interaction leading to a decondensed chromatin structure (Luger et al., 1997). Alternatively, 
H4K16Ac recognition by a bromodomain could lead to the recruitment of a complex that 
catalyses chromatin decondensation. Bromodomains are one of a small family of distinct 
histone binding modules found in chromatin binding proteins that recognize specific
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Model for the assembly of the D. melanogaster dosage compensation complex on 
the male X chromosome. MSL1-MSL2 forms the core of the complex and can autonomously 
interact with the X chromosome. MOF and MSL3 interact with MSL1. MLE is likely to 
transiently interact with the roX RNA. All of the components are essential for a functional 
dosage compensation complex (Kelley et al., 1999). 
Chromatin 
roX RNA 
MSL1 
MSL2 
MSL1 
MSL2 
MSL1 
MSL2 
MSL3 
MOF 
MLE 
 14 
histone post-translational modifications (Taverna et al., 2007) (Table 1.2). Hence both cis-
acting and trans-acting mechanisms are plausible options for nucleosome decondensation. 
Acetylation of H4 K16 (H4K16Ac) is a post-translational modification enriched upon 
the male single X chromosome. It is catalyzed by MOF and is essential to dosage compensation 
in D. melanogaster (Akhtar and Becker, 2000; Smith et al., 2000). In the absence of MOF the 
H4K16Ac of the male X chromosome is rapidly lost (Akhtar and Becker, 2000). H4K16Ac is 
deacetylated by the histone deacetylase Rpd3 (Buscaino et al., 2003). The counteracting 
activities of MOF and Rpd3 are likely to regulate dosage compensation. 
Histone acetyltransferases, such as the MYST family member MOF catalyze the 
transfer of an acetyl group from acetyl-coenzyme A (AcCoA) to the ζ-nitrogen of a lysine’s 
amino group. The crystal structures of the MYST family yEsa1 (Essential Sas-related 
acetyltransferase 1) and the Gcn5/PCAF family Gcn5 HAT domains have been reported at high 
resolution (Trievel et al., 1999; Yan et al., 2002). Despite belonging to separate HAT families 
their structures reveal a structural conservation of the central core involved in AcCoA binding 
and both share a conserved glutamate residue essential to catalysis (Yan et al., 2002). Despite 
this observed structural conservation, Gcn5 and Esa1 were proposed to operate by separate 
mechanisms. Gcn5 catalyses the direct nucleophilic attack of the AcCoA by the deprotonated ζ-
nitrogen of lysine (Trievel et al., 1999). Esa1 was initially reported to have a ping-pong 
mechanism, transfer of the AcCoA acetyl group to the deprotonated ζ-nitrogen of lysine 
proceeding via an acetyl-Cys residue intermediate (Yan et al., 2002). Recent studies using 
recombinant Esa1 incorporated into the piccolo NuA4 complex suggests that its mechanism 
actually proceeds via direct nucleophilic attack (Berndsen et al., 2007). The piccolo NuA4 
(picNuA4) complex is a smaller NuA4 complex, containing only Esa1, Epl1, and Yng2 
(Boudreault et al., 2003). MOF, a MYST family member is likely to have a similar mechanism 
based upon conservation of essential residues. 
Integration of MOF into the dosage compensation complex confers a male X 
chromosome specific H4K16Ac distribution, which leads to a decondensed chromatin structure 
and facilitates its two-fold transcriptional upregulation (Turner et al., 1992). The decondensed 
chromatin structure of the male X chromosome likely facilitates transcriptional upregulation 
through permitting greater accessibility of RNA polymerase and its associated factors. The 
yeast S. cerevisiae HATs Gcn5 (part of the SAGA complex) and Esa1 (part of the NuA4 
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complex) specifically acetylate promoter regions (Bhaumik and Green, 2001; Smith et al., 
1998). Acetylation at the 5’ promoter region is proposed to promote transcription initiation by 
creating a nucleosome free region (Allard et al., 1999; Kuo et al., 1998), recruitment of TATA-
binding protein (TBP) and RNA polymerase II (polII) (Qiu et al., 2004) and coactivators 
(Govind et al., 2005). The enriched 3’ distribution of H4K16Ac by MOF in the dosage 
compensation complex is proposed to facilitate transcriptional elongation on the male X 
chromosome rather than transcriptional initiation (Smith et al., 2001). 
 
Table 1.2: Chromatin binding domains. Synopsis of histone post-translational modifications 
(methylation [Me], phosphorylation [ph], acetylation [Ac]) and the conserved domains that 
recognize them. Table is based upon Figure 1 from (Taverna et al., 2007). 
 
 
 
      
Domain PTM Example 
      
   
Bromodomain KAc Gcn5 
      
   
Tudor Royal Family   
Chromodomain H3K9Me2/3, H3K27Me2/3 HP1 
Double chromodomain H3K4Me1/2/3 CHD1 
Chromo barrel H3K36Me2/3 Eaf3 
Tudor RMe2  
Tandem Tudor H3K4Me3, H4K20Me3, H4K20Me1/2 JMJD2A 
MBT H4K20Me1/2, H1K26Me1/2, H3K4Me1, H3K9Me1/2 L3MBTL1 
      
   
PHD finger H3K4Me3, H3K4Me, H3K9Me3 BPTF 
      
   
WD40 H3R2/K4Me2 WDR5 
      
   
14-3-3 H3S10ph, H3S28ph 14-3-3ξ 
      
   
BRCT H2AX-S139ph BRCA1 
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1.5.2  ATP-dependent Nucleosome Remodeling and Dosage Compensation 
The regulators and enzymes of transcription, recombination, replication and repair 
require access to their respective DNA targets, which a nucleosome would otherwise block. A 
repressive local chromatin structure is altered to permit these processes by nucleosome 
remodeling complexes. Nucleosome remodeling complexes catalyze the ATP-dependent sliding 
of nucleosomes to neighboring DNA sequences. Nucleosome remodelers within all eukaryotes 
fall into one of five families: SWI/SNF, ISWI, NURD/Mi2/CHD, and INO80/SWR1 (Becker 
and Horz, 2002). The molecular engines of these diverse complexes are homologous ATPases. 
Homologues are differentiated based upon sequence variability outside of their ATPase 
domain. The first class of ATPase, Swi2/Snf2, was identified in S. cerevisiae in a screen that 
identified the switch of mating type and sucrose-nonfermenting mutations and is part of the 11-
subunit SWI/SNF complex (Sudarsanam and Winston, 2000; Vignali et al., 2000). The Brahma 
(BRM) ATPase, a SWI/SNF homologue in D. melanogaster is part of the BRM complex 
(Elfring et al., 1994). BRM is involved in RNA polymerase II (Pol II) regulation, elongation 
and development (Armstrong et al., 2002; Srinivasan et al., 2005; Zraly et al., 2004). The 
ATPase ISWI (imitation switch) was later identified in D. melanogaster based upon homology 
with BRM. ISWI ATPases are characterized by two SANT-like DNA-binding domains 
(Aasland et al., 1996). ISWI is present in three complexes, NURF (nucleosome remodeling 
factor), CHRAC (chromatin accessibility complex), and ACF (ATP-utilizing chromatin 
assembly and remodeling factor) (Langst and Becker, 2001). These complexes function in the 
formation and disruption of higher ordered chromatin structures, which are repressive to 
fundamental DNA processes. The antagonistic effects of these complexes depends whether they 
catalyze a succession of nucleosomes into an ordered array (Varga-Weisz et al., 1997), which 
would facilitate the formation of a higher ordered chromatin structure or catalyze the disruption 
of ordered nucleosomal arrays (Tsukiyama and Wu, 1995). 
ATP-dependent nucleosome remodeling complexes play a key role in dosage 
compensation in D. melanogaster by fine-tuning the two-fold transcriptional activation of the 
male X chromosome. ATP-dependent nucleosome remodeling complexes that disrupt ordered 
nucleosomal arrays promote euchromatin formation and would therefore be complimentary to 
the function of the DCC. Complexes that catalyze the formation of ordered nucleosomal arrays 
promote heterochromatin formation, which would be antagonistic. The function of the ISWI 
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ATPase appears to be directly antagonistic to MOF, catalyzing ordered nucleosomal arrays, 
which promotes a repressive chromatin structure. Homozygous ISWI null mutant male larvae 
exhibit a highly decondensed X chromosome. The autosomes and female X chromosomes 
exhibit a wild-type phenotype. This decondensed male phenotype is not observed in larvae with 
homozygous ISWI and mle mutations (Corona et al., 2002). MLE is essential to the function of 
the DCC (Gu et al., 2000), therefore the function of ISWI and the DCC is antagonistic. The N-
terminal tail of histone H4 alone is pivotal to the interplay between these complexes in dosage 
compensation. When the H4 N-terminal tail is deleted ISWI loses its ATPase activity and 
NURF and CHRAC subsequently lose their ability to catalyze the nucleosome sliding. (Clapier 
et al., 2001; Hamiche et al., 2001). The crucial component of the H4 histone N-terminal tail for 
ISWI activity is the stretch of residues K16R17H18R19 (Clapier et al., 2002). It is the DCC 
dependent H4K16 acetylation of this stretch of residues that specifically antagonizes ISWI 
function. Acetylation of H4K16 inhibits ISWI ATPase activity and nucleosomal sliding 
(Corona et al., 2002). 
The non-translated RNA roX1 and roX2 are integral components of the DCC in D. 
melanogaster and function in complex assembly and targeting to the males single X 
chromosome (Kelley et al., 1999; Peterson and Laniel, 2004). Like H4K16 acetylation, the roX 
RNAs are essential to the antagonistic interplay between ATP-dependent nucleosomal 
remodelers and the DCC in D. melanogaster. NURF is a four subunit complex (NURF301, 
NURF55, NURF38, and ISWI) that functions as an activator and repressor of transcriptional 
activity (Badenhorst et al., 2005; Xiao et al., 2001). Like in the homozygous ISWI null mutant, 
the male X chromosome exhibits a highly decondensed structure in NURF301 mutant males. 
This phenotype is not suppressed if either roX1 or roX2 is concomitantly deleted. Interestingly, 
unlike H4K16 acetylation, which suppresses the action of ISWI, NURF represses the action of 
the DCC by repressing transcription of the roX genes (Bai et al., 2007).  
ATP-dependent nucleosomal remodeling complexes also have the ability to generate 
positive superhelical torsion in DNA, which further propagates the formation of repressive 
higher ordered chromatin. It is therefore not surprising that DNA supercoiling factor (SCF), a 
protein that introduces negative supercoils, which would be antagonistic to the action of ATP-
dependent nucleosome remodelers is associated with the action of the DCC. SCF interacts 
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directly with the DCC and when overexpressed causes the male X chromosome to be highly 
decondensed. This phenotype is suppressed by the ISWI mutation (Furuhashi et al., 2006).  
The D. melanogaster GAGA factor, encoded by Trithorax-like (Trl) functions in the 
formation of nucleosome-free regions of chromatin and is implicated in DC. Trl hypomorphs (a 
mutant gene with weaker effect than the corresponding wild-type gene) show reduced male 
viability and redistribution of the DCC to autosomes (Greenberg et al., 2004).  
 
1.6  Dosage Compensation Complex: Structure and Localization 
Dosage compensation in D. melanogaster involves the two-fold transcriptional 
upregulation of the males single X chromosome, a finely tuned epigenetic process that involves 
the coordinated post-translational modification and remodeling of the chromatin structure. 
Central to the modulation of the chromatin structure is the ribonucleoprotein DCC, which 
paints the male X chromosome and is responsible for global H4K16 acetylation (Akhtar and 
Becker, 2000). A functional DCC comprises MSL1, MSL2, MSL3, MOF, MLE, roX1 and/or 
roX2 (Belote and Lucchesi, 1980). The two roX RNAs share very little sequence similarity and 
appear to be redundant in their function (Meller and Rattner, 2002). Knockout of either subunit 
of the DCC abolishes DC. MSL1 and MSL2 form the core of the complex, which can bind to 
approximately thirty to sixty cytologically distinct sites on the male X chromosome in an msl3, 
mof, or mle knockout (Demakova et al., 2003; Kelley et al., 1999). MSL1 recognizes these high 
affinity sites via a conserved basic motif at the N-terminus (1-26). Heterodimerization with 
MSL2 is essential for recognition (Akhtar and Becker, 2000; Li et al., 2005b). MSL1 and 
MSL2 heterodimerize via a two-stranded, α-helical, coiled-coil structure (Scott et al., 2000). 
Coiled-coil structures are formed by a heptad repeat  (abcdefg)n where a and d are typically 
small hydrophobic residues and e and g are charged amino acids (Cohen and Parry, 1990). The 
region of MSL2 that is likely to form the coiled-coil (25-40) precedes a RING finger domain, 
the integrity of which is essential to interaction with MSL1 (Copps et al., 1998). The region 
within MSL1 that forms the coiled-coil structure is at the N-terminus, C-terminal to the 
nucleosomal binding basic motif (Li et al., 2005b). Li et al. (2005b) noted that a truncated 
MSL1 construct containing only the first 265 amino acids (1-265) was able to bind hundreds of 
sites along the male X chromosome, but was only able to bind the approximately thirty high 
affinity sites in the absence of endogenous MSL1 (Li et al., 2005b). Experimental evidence 
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demonstrated that this is due to self-association via a glycine-rich motif (26-50), between the 
basic motif and the coiled-coil motif allowing for the truncated mutant to bind to wild-type 
complex. Li et al. (2005b) suggest that complex formation at these high affinity sites facilitates 
the cooperative binding of the complex to proximal sites of weaker affinity via self-association 
of MSL1. Interactions of the N-terminus of MSL1 are summarized in Figure 1.6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Schematic representation of the D. melanogaster MSL1 protein. Its N-terminus is 
involved in binding the male X chromosome (1-26), self association (26-50) and interaction 
with MSL2 (96-159). The C-terminus is involved in binding MSL3 and MOF. Mutation of K3, 
R4, and K6 restricts binding of MSL1 to approximately 5 of the high affinity entry sites (Li et 
al., 2005b; Smith et al., 2005). 
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Interestingly, two of the thirty high affinity sites are the roX1 and roX2 genes. Despite 
differential expression roX1 and roX2 appear to be functionally redundant (Meller, 2003; 
Meller and Rattner, 2002). The concomitant deletion of roX1 and roX2 however causes a 
dramatic relocalization of the DCC to the autosomes and pericentric heterochromatin (Meller 
and Rattner, 2002). The roX RNAs therefore play a role in the correct localization of the 
complex. The key determinant in conferring male X chromosome specificity appears to be the 
C terminus of MSL2 (Marin, 2003). Binding of roX1 and its incorporation into the complex 
requires proline-rich and basic motifs in the C-terminus, with the aid of MLE, which can bind 
roX1 autonomously and weakly interacts directly with the C-terminus of MSL2 (Li et al., 2008; 
Meller et al., 2000). 
While the N-terminus of MSL1 and MSL2 are sufficient for recognition of 
pericentromeric heterochromatin and the X chromosome high affinity sites, normal binding of 
the hundreds of sites along the X chromosome requires proline rich and basic motifs in the C-
terminus of MSL2 (Li et al., 2008; Meller et al., 2000).  
MOF, MLE, and MSL3 have been demonstrated to bind RNA (Akhtar et al., 2000; Izzo 
et al., 2008; Morales et al., 2005; Richter et al., 1996). It is therefore likely that they associate 
with the MSL1/MSL2 core concomitant with, or after roX incorporation. Binding of roX RNA 
by MOF and MSL3 is not crucial to integration into the DCC (Oh et al., 2003). The C terminus 
of MSL1 is the key determinant involved in the direct binding of MOF and MSL3. MOF binds 
to a region of the MSL1 C terminus that contains a conserved PEHE domain (766-939) via its 
C2HC zinc finger (Marin, 2003; Morales et al., 2004). MOFs C2HC zinc finger is also essential 
to autonomous nucleosome recognition and its HAT activity (Akhtar and Becker, 2001). The 
MOF binding site is distinct from the MSL3 binding site (973-1039) (Morales et al., 2004). 
MSL3 binds to the C-terminus of MSL1 (973-1039) via its C –terminal MRG domain (Morales 
et al., 2005). The domain structure and interactions between components of the dosage 
compensation complex are shown in Figure 1.7. 
The likely dual function of MOF has been previously discussed along with the male 
specific global enrichment of H4K16Ac on the male X chromosome, which is catalyzed by 
MOF incorporated into the DCC. Specificity of MOF for H4K16 of male X chromosome 
nucleosomes is conferred synergistically by complex formation with MSL1 and MSL3 
(Morales et al., 2004). MOF and MSL3 must be bound to MSL1, and MOF and MSL3 must
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Figure 1.7: Schematic representation of the MSL1, MSL2, MSL3, MOF, and MLE domain 
structure. Interactions are denoted by a red line. 
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directly interact for specificity and increase in acetylase activity (Morales et al., 2004). Morales 
et al. (2004) also noted that when not in complex MOF autoacetylated and acetylated MSL1 
and MSL3. The acetylation state of MSL3 may be important to its incorporation into the DCC. 
MSL3, specifically acetylated at K116 by MOF no longer localizes to the X chromosome, 
implying that acetylation prevents its integration into the DCC (Buscaino et al., 2003). Note, 
some skepticism exists as to whether MSL3’s incorporation into the DCC is acetylation-
dependent as K116 is not conserved in other Drosophila homologues (personal communication 
Dr. S. A. Moore). The findings of Buscaino et al., 2003 have also not been corroborated by 
other laboratories. 
Acetylation of MSL3 at K116 prevents X chromosome localization via interrupting the 
interaction with roX2. MOF-dependent acetylation of MSL3 is counteracted by the histone 
deacetylase Rpd3, which interacts directly with MSL3 (Buscaino et al., 2003). Rpd3 is also 
likely to be responsible for the deacetylation of H4K16Ac (Akhtar and Becker, 2000). This 
interplay of two enzymes with opposing activities in the regulation of chromatin post-
translational modification and ultimately chromatin structure is not unique. The S. cerevisiae 
NuA4 complex, which contains the MOF HAT paralogue Esa1 has previously been discussed. 
The complex also contains an MSL3 paralogue, Eaf3 (Esa1 associated factor 3). Eaf3 governs 
the complex’s specificity for acetylating H3 and H4 of nucleosomes at promoter regions over 
protein-coding regions (Joshi and Struhl, 2005; Morales et al., 2005; Reid et al., 2004). Eaf3 is 
found in the NuA4 HAT complex and in the Rpd3S and Rpd3L HDAC complexes (Carrozza et 
al., 2005; Gavin et al., 2002; Reid et al., 2004). Acetylation of ORF nucleosomes facilitates 
transcriptional elongation. To prevent intragenic transcription initiation this post-translational 
modification is removed after the passage of RNApol II via methylation of H3K36 by the 
histone methyltransferase SET2, which directly interacts with the C-terminal domain of 
RNApol II via its Set2 Rpb1 interacting (SRI) domain (Kizer et al., 2005; Krogan et al., 2003). 
The H3K36Me3 post-translational modification is then recognized by the Rpd3S complex via 
the coupled action of the chromodomain of Eaf3 and the PHD domain of Rco1 (Joshi and 
Struhl, 2005; Li et al., 2007a). The coupled recognition of H3K36Me3 explains why the NuA4 
complex, which contains Eaf3 but not Rco1 does not recognize H3K36Me3 modified 
nucleosomes (Li et al., 2007a). Eaf3 therefore plays a crucial role in linking Rpd3 catalyzed 
histone deacetylation to RNApol II elongation in yeast. It is unclear if MSL3 functions in 
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distinct HAT and HDAC complexes in D. melanogaster but the localization of the DCC and 
specifically MSL3 have been demonstrated to overlap with the localization of H3K36Me3 and 
H3K4Me modified nucleosomes (Larschan et al., 2007). Methylation of H3K36 by the 
methyltransferase Hypb in D. melanogaster has been demonstrated to recruit the DCC and 
promote H4K16 acetylation (Bell et al., 2008). The highly conserved nature of the interaction 
and the similar actions of the DCC and NuA4 complex suggests that MSL3 will play a similar 
role to Eaf3. 
Along with the histone deacetylase Rpd3, a histone kinase, JIL1 is also transiently 
associated with the DCC. JIL1 is an Aurora B homologue that specifically phosphorylates 
H3S10 and associates with gene-rich interband regions. It is essential to both sexes, however is 
enriched upon the male X chromosome (Jin et al., 1999). JIL1 hypomorphs (a mutant gene with 
weaker effect than the corresponding wild-type gene) that are not lethal exhibit a decondensed 
chromatin structure phenotype, which is most severe on the male X chromosome. The 
decondensed chromatin structure is concomitant with decreased levels of H3S10 
phosphorylation (Deng et al., 2008; Wang et al., 2001). The role of JIL1 is likely to prevent the 
formation of a repressive heterochromatin state, complementing the action of the DCC. H3S10 
phosphorylation by Aurora B has been demonstrated to displace heterochromatin protein 1 
(HP1), which is involved in heterochromatin formation (Hirota et al., 2005; Mateescu et al., 
2004). HP1 recognizes di- and tri-methylated H3K9 via its chromodomain. H3K9Me2/3 is an 
epigenetic mark associated with heterochromatin formation and is catalyzed by the 
methyltransferase Su(var)3-7 (Jacobs and Khorasanizadeh, 2002; Nielsen et al., 2002). The role 
of HP1 directly antagonizes that of the DCC in dosage compensation of the male X 
chromosome, promoting transcriptionally repressive chromatin formation and likely functions 
to regulate the degree of transcriptional upregulation (Kizer et al., 2005).  
The involvement of both H3S10 phosphorylation and H4K16 acetylation in dosage 
compensation in D. melanogaster is not a novel paradigm in transcriptional activation. 
Stimulation of mammalian cells with epidermal growth factor (EGF) causes the sequential 
phosphorylation and acetylation of H3 N-terminal tails and the histone acetyltransferases Gcn5 
exhibits a ten-fold increase in substrate specificity for H3S10 phosphorylated H3 N-terminal 
tails over unmodified N-terminal tails (Cheung et al., 2000). 
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Determinants that govern the specific targeting of the DCC to the male X chromosome 
are poorly understood. Distribution of the DCC on the male X chromosome, visualized via 
immunofluorescence studies of the male polytene chromosome from larval salivary glands 
shows a discontinuous banding pattern of hundreds of sites along the X chromosome. As 
discussed earlier (section 1.6) it is understood that a subset of approximately thirty to sixty 
entry sites of high affinity for the DCC exist from which the complex spreads in cis via the 
cooperative binding of additional DCCs to sites of weaker affinity (Demakova et al., 2003). 
Chromatin immunoprecipitation studies coupled with high-resolution micro-arrays (ChIP-chip) 
reveals that genes are preferred targets over intergenic regions and that DCC distribution within 
the gene is strongest towards the 3’ transcribed end with preference for coding sequences 
(Gilfillan et al., 2006). The pattern of distribution is relatively stable between distinct cell lines 
and development (Legube et al., 2006). However, DCC distribution is not a direct marker of 
dosage compensation as numerous genes that are dosage compensated are not sites of DCC 
localization (Legube et al., 2006). Also the targeting determinant does not appear to be 
transcriptionally dependent, though localization does appear to be coupled with an active 
transcriptional state as genes showing the highest levels of bound DCC are the most 
compensated (Gilfillan et al., 2006). A link between DC and transcription seems important as it 
prevents the ectopic expression of genes that are not being expressed. The observation by 
Legube et al. (2006) that greater than 66% of transcribed X-linked genes are dosage 
compensated whereas only approximately 15% are bound by MSL1 suggests that the DCC has 
long-range action. The authors suggest that dosage compensation regions are organized into 
distinct domains, which have unique transcriptional properties (Legube et al., 2006). 
Alekseyenko et al. (2006) carried out a similar study in two male cell lines and in late-stage 
embryos. They demonstrated an enriched distribution of the DCC complex over expressed 
genes, and that distribution was enriched towards the 3' end of the gene. Differential binding 
between the cell lines led them to conclude that sequence alone is not sufficient to explain the 
pattern of distribution, rather that chromatin factors and/or histone post-translational 
modifications indicative of active transcription are responsible (Alekseyenko et al., 2006).  
Association of the hypertranscribed male X chromosome with the nuclear pore complex 
at the nuclear periphery supports this theory (Mendjan et al., 2006). The nuclear pore complex 
(NPC) is a regulatory complex at the nuclear periphery involved in gene expression and RNA 
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export (Schmid et al., 2006). Interestingly, RNAi knockdown of Mtor and Nup153 expression 
led to loss of DCC (Mendjan et al., 2006).  Association of the male X chromosome and 
physical interaction between the DCC and the NPC supports the theory that dosage 
compensation regions are organized into distinct domains. 
The structure, components and interactions of the DCC are diverse and intricate and 
whose global action involves epigenetic regulation via the post-translational modification and 
restructuring of local chromatin to facilitate the two-fold upregulation of the D. melanogaster 
males X chromosome. The components of the DCC complex and synergistic and antagonistic 
complexes, which began with identification of the male-specific lethal proteins have 
subsequently been expanded to include Rpd3, JIL1, GAGA factor, supercoiling factor (SCF), 
ATP-dependent nucleosome remodelers, and components of the nuclear pore. The list is likely 
to expand as research in this field progresses. 
 
1.6.1  Dosage Compensation Complex in Humans 
A H4K16 specific histone acetyltransferase complex containing MOF, MSL1, MSL2, 
and MSL3 orthologues exist in humans (Marin, 2003; Smith et al., 2005). In humans the 
females dosage compensate by inactivating large regions of one of their X chromosomes, 
forming a Barr body, to compensate for the males single X chromosome (Lyon, 1961). Unlike 
its D. melanogaster counterpart the human complex is not thought to function in dosage 
compensation and is not specific to males or the X chromosome. The human complex is 
responsible for the majority of H4K16 acetylation and is implicated in DNA repair and the 
G2/M cell cycle arrest checkpoint in response to DNA damage (Gupta et al., 2005).  
 
1.7  The Tudor Royal Family and Chromodomains of the Dosage Compensation 
Complex 
Chromodomains were first identified in two known modulators of chromatin structure in 
D. melanogaster, HP1 and Polycomb (PC), which share a “chromo-box” sequence motif. HP1 
and PC are involved in constitutive heterochromatin formation and silencing of cell type-
specific homeotic gene expression, respectively (Cao et al., 2002; Elgin, 1996; Paro et al., 
1998). Chromodomains (chromatin organization modifier domains) are members of the Tudor 
Royal family, sharing a conserved three β-stranded core region and are key components of 
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epigenetic regulation (Maurer-Stroh et al., 2003). Chromodomains are a paradigm of how a 
single structural fold has evolved in diverse proteins to bind distinct targets. Chromodomains 
are common to nuclear regulators and bind diverse targets including histones, DNA, and RNA 
(Akhtar et al., 2000; Bouazoune et al., 2002; Lachner et al., 2001). They function as 
recognition motifs of histone post-translational modifications and facilitate the translation of the 
histone code into a distinct local chromatin structure via recruiting the appropriate chromatin 
modulating machinery, as illustrated by Eaf3s chromodomains recognition of the H3K36Me3 
epigenetic mark and recruitment of the Rpd3S complex, discussed earlier (section 1.6) (Joshi 
and Struhl, 2005).  
 
1.7.1  HP1 and Polycomb: Structure and Function 
The chromodomain fold of HP1 is a three-stranded antiparallel β−sheet with an α-helix 
packed against the β-strands (Jacobs and Khorasanizadeh, 2002; Nielsen et al., 2002). The fold 
is structurally homologous to the DNA binding protein Sso7d, a chromosomal binding protein 
from the hyperthermophilic archaebacteria Sulfolobus solfataricus (Gao et al., 1998). HP1 
binds methylated H3K9, an epigenetic marker associated with gene silencing. H3K9 
methylation is catalyzed by the histone methyltransferase Su(var)3-9 (Lachner et al., 2001). 
The crystal structure of the HP1 chromodomain bound to a H3K9Me2/3 peptide reveals that the 
modified histone tail binds to HP1 via insertion of the tail as a β-strand completing a β-
sandwich fold (Figure 1.8). The methyl-ammonium group is buried in a hydrophobic cage, 
formed by the side chains of Y24, Y48, and W45 (Figure 1.9). 
Polycomb specifically binds tri-methylated H3K27. Methylation of H3K27 is catalyzed 
in D. melanogaster by an Enhancer of Zeste (E[z]) and Extra Sex combs (ESC) complex 
(Czermin et al., 2002). The structures of the PC and HP1 chromodomains are highly similar. 
The H3K27Me3 binds in a similar mechanism, the peptide incorporating as a β-strand and the 
methyl-ammonium group buried in a hydrophobic cage formed by the side chains of Y26, W47, 
and W50. When the structures are overlaid the chromodomain and peptide Cα positions only 
deviate by a pair-wise root-mean-squared-difference (rmsd) of 1.1 Å and 0.45 Å, respectively 
(Min et al., 2003). Specificity of dPC for H3K27Me3 appears to be achieved via dimerization of 
the dPC chromodomain. HP1 does not dimerize. Dimerization of dPC positions the H3K27Me3 
N-terminal tails in close proximity with each other across the dimer interface allowing for 
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histone-histone interaction between adjacent histone H3 tails. If H3K9Me were to bind in a 
similar fashion Arg 2 and Lys 4 would form significant steric conflicts (Cowell and Austin, 
1997; Min et al., 2003). 
 
 
Figure 1.8: Structure of the HP1 chromodomain. The chromodomain fold of HP1 is a three-
stranded antiparallel β−sheet with an α-helix perpendicular to the β-strands. A backbone trace 
reveals incorporation of the H3K9Me2 peptide as a β-strand completing the β-sandwich. Figure 
taken from (Jacobs and Khorasanizadeh, 2002). 
 
 
 
 
Figure 1.9: Hydrophobic binding pocket of HP1. The H3K9Me3 (red peptide, green structure) 
structure is shown overlaid with that of the H3K9Me2 (yellow peptide, blue structure) structure. 
Van der Waals radii are shown for the H3K9Me3 structure. Figure taken from (Jacobs and 
Khorasanizadeh, 2002). 
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1.7.2  Cooperativity within the Tudor Royal Family  
The concerted action of two domains in the recognition of a specific methyl-lysine mark 
is also observed in the demethylase JMJD2A, a Jmjc-domain family member, whose C-terminal 
double Tudor domains recognizes and binds histones methylated at H3K4 or H3K20 with 
similar affinities (Kd=0.50µM and Kd=0.40µM, respectively) (Huang et al., 2006; Lee et al., 
2008; Tsukada et al., 2006). The structure of the double tudor domains complexed with a 
H3K4Me3 peptide reveals two canonical tudor domains interdigitated by two β-strands, β2 and 
β3, which both domains share (Figure 1.10). The recent publication of the JMJD2A- 
H3K20Me3 complex structure reveals that binding of the two peptides is distinct. Despite 
methyl-lysine binding involving the same aromatic cage residues the peptide orientation is 
opposite and contacts different surfaces (Lee et al., 2008). 
 
 
 
 
                                                  Tudor Domain 1                                          Tudor Domain 2 
 
 
 
 
 
 
Figure 1.10: Structure of the JMJD2A double Tudor domains in complex with H3K4Me3 
(blue). The double Tudor domains of are interdigitated by β-strands β2 and β3. Figure taken 
from (Huang et al., 2006). 
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The H3K4Me3 peptide is predominantly bound by the second domain. Like the 
chromodomains of HP1 and PC the methyl-ammonium group is buried in a hydrophobic cage. 
The hydrophobic cage is formed by W967 and Y973, of the second domain and F932 of the 
first domain. Specificity is conferred via side-chain interactions between the second domain and 
the peptide (Figure 1.11). Unlike HP1 and PC the histone tail is not incorporated as a β-strand 
(Huang et al., 2006). 
53BP1 (p53 binding protein 1), involved in the DNA damage check-point signal also 
contains a double Tudor domain but they are not interdigitated and form two separate domains. 
The NMR structure reveals the tudor domains to have a β-barrel structure with close 
evolutionary relationship to the tudor domain of Survival of Motor Neuron (SMN), which is 
thought to bind a RG rich motif (Charier et al., 2004; Selenko et al., 2001; Sprangers et al., 
2003). The closely related malignant brain tumor repeats of human L3MBTL1 have been 
shown to bind a monomethylated lysine histone substrate, suggesting that the SMN domain 
may have a similar function (Li et al., 2007b). 
 
 
 
 
Figure 1.11: Binding of H3K4Me3 by the double Tudor domains of JMJD2A. The methyl-
ammonium group is bound by W967 and Y973, of the second domain and F932 of the first 
domain. Specificity is conferred via side-chain interactions between the second domain and the 
peptide. Figure taken from (Huang et al., 2006). 
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Interestingly the double Tudor domain of 53BP1 binds H4K20Me2. The interaction 
involves Van der Waals π-cation interactions between the dimethyl-lysine and a hydrophobic 
cavity formed by the side chains of W1495, Y1502, F1519, and Y1523. Specificity for 
dimethyl-lysine over trimethyl-lysine is conferred via a salt-bridge between the carboxylate 
group of D1521 and the methyl-ammonium group of H4K20Me2. A hydrogen bond between 
the carboxylate group of D1521 and the amino proton of H4K20Me2 is also likely to confer 
specificity. Trimethyl-lysine does not have the amino hydrogen and would therefore not be able 
to form the hydrogen bond (Botuyan et al., 2006). 
The double chromodomains of the chromatin remodeling protein CHD1 (chromo-
ATPase/helicase-DNA binding domain 1) of the SAGA and SLIK acetyltransferase complexes 
also act cooperatively to bind their target, H3K4Me (Flanagan et al., 2005; Pray-Grant et al., 
2005). The crystal structure of the CHD1 double chromodomain complexed with an H3K4Me3 
peptide reveals the two chromodomains are linked by a helix-loop-helix structure and that both 
chromodomains have similar secondary structure to that of HP1 and PC. The H3K4Me3 group 
is bound at the interface of the two chromodomains. Two aromatic residues, W64 and W67 
from chromodomain 1 interact with the methyl-ammonium group unlike HP1 and PC, which 
use the canonical three aromatic residue cage. The π-cation interaction between the methyl-
ammonium group and W64 and W67 is further stabilized by a π-cation interaction between R2 
of the H3K4Me3 peptide and W67. This interaction is proposed to confer specificity for 
methylated H3K4 (Figure 1.12). Chromodomain 2 of CHD1 has only one of the two aromatic 
residues and is therefore unable to bind the methyl-ammonium group. In both HP1 and PC, the 
H3 peptide inserts as a β-strand completing the chromodomains β-sandwich fold. An insertion  
novel to chromodomain 1 of CHD1 plays this role, and thus prevents peptide binding in a 
manner homologous to HP1 or PC. Rather the H3K4 peptide is bound at the domain interface 
(Flanagan et al., 2005). It is interesting to note that binding of HP1 and the CHD1 
chromodomains to their respective targets is abrogated by phosphorylation of H3S10 or H3T3, 
respectively (Flanagan et al., 2005; Hirota et al., 2005). The double chromodomain of the 
CHD1 isoform Mi-2 in D. melanogaster does not bind H3K4Me3, rather it has been shown to 
bind DNA (Bouazoune et al., 2002), though some believe this to be unlikely. 
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Figure 1.12: Binding of H3K4Me by the double chromodomain of CHD1. The H3 peptide is 
bound by two aromatic residues, W64 and W67, which are further stabilized by interaction of 
R2 with W67. H3K4Me (yellow), H3K4Me3 (green), H3K4Me3R2Me2 (cyan), H3K4Me3T3ph 
(red). Figure taken from (Flanagan et al., 2005). 
 
  
1.7.3  The Chromodomains of MOF and MSL3 
MOF and MSL3, two components of the DCC contain chromodomains (Figure 1.7). To 
date no direct evidence exists suggesting that MOF binds a methyl-lysine epigenetic mark.  The 
MSL3 chromodomain has been demonstrated to recognize H3K36Me3 (Bell et al., 2008; 
Larschan et al., 2007). The chromodomain of Eaf3, an MSL3 paralogue in S. cerevisiae has 
also been demonstrated to recognize methylated H3K36 (Joshi and Struhl, 2005). Sequence 
alignment of the MOF and MSL3 chromodomains with HP1 and PC reveals that MSL3 exhibits 
the three conserved aromatic residues associated with forming the hydrophobic cage that binds 
the methyl-ammonium group of a methylated lysine residue in HP1 and PC. MOF however 
does not exhibit the three conserved aromatic residues (Figure 1.13). 
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                         β1              β2 
 
 
dMOF          QKIDISENPDKIYFIRREDG----TVHRGQVLQSRTTEN---------------- 
hMOF          GEPEVTVEIGETYLCRRPDS----TWHSAEVIQSRVNDQ---------------- 
yEsa1         INSVDDIIIKCQCWVQKND-----EERLAEILSINT------------------- 
dMRG15        TDANTLFVDGERVLCFHGP-----LIYEAKVLKTKPDA----------------- 
hMRG15        IDPKPKFQEGERVLCFHGP-----LLYEAKCVKVAIKD----------------- 
dMSL3         RDETPLFHKGEIVLCYEPDKSKARVLYTSKVLNVFERRN---------------- 
hMSL3         EGMKFKFHSGEKVLCFEPDPTKARVLYDAKIVDVIVGKD---------------- 
yEaf3         VDLEQEFALGGRVLAFHGP-----LMYEAKILKIWDPSSKMYTSIPNDKPGGSSQ 
dPc           -----GKGSKGKLGRDNATDDPVDLVYAEEKIIQKRVKK---------------- 
dHP1          -----KKIDNPESSAKVSDAEEEEEEYAVEKIIDRRVRK---------------- 
 
 
                                              β1 
 
                                            β3            β4        β5 
 
dMOF          -------------------AAAPDEYYVHYVGLNRRLDGWVGRHRISDNADDLGG 
hMOF          --------------------EGREEFYVHYVGFNRRLDEWVDKNRLALTKTVKDA  
yEsa1         -------------------RKAPPKFYVHYVNYNKRLDEWITTDRINLDKEVLYP 
dMRG15        ---------------------TPVEYYIHYAGWSKNWDEWVPENRVLKYNDDNVK 
hMRG15        ---------------------KQVKYFIHYSGWNKNWDEWVPESRVLKYVDTNLQ 
dMSL3         -----------------EHGLRFYEYKIHFQGWRPSYDRCVRATVLLKDTEENRQ 
hMSL3         -----------------EKGRKIPEYLIHFNGWNRSWDRWAAEDHVLRDTDENRR 
yEaf3         ATKEIKPQKLGEDESIPEEIINGKSFFIHYQGWKSSWDEWVGYDRIRAYNEENIA 
dPc           ---------------------GVVEYRVKWKGWNQRYNTWEPEVNILDRRLIDIY 
dHP1          ---------------------GKVEYYLKWKGYPETENTWEPENNLDCQDLIQQY 
 
                                           
                                          β2                β3         α1 
 
Figure 1.13: Sequence alignment of the MOF and MSL3 chromodomains of the DCC with 
their homologues yEsa1, hMOF, hMSL3, yEaf3, dMRG15, hMRG15 and archetypal 
chromodomains HP1 and PC. Secondary structure elements are shown in grey for HP1 and 
black for MOF. Residues involved in forming the methyl ammonium binding hydrophobic cage 
are highlighted in yellow. Conserved residues are shown in blue, broadly conserved residues in 
purple. Important residues that differ between MOF and MSL3 are shown in red. 
 
 
Akhtar et al. (2000) provided preliminary evidence supporting the involvement of the 
MOF and MSL3 chromodomains in binding RNA, and that their association with the DCC is 
RNAse sensitive (Akhtar et al., 2000; Smith et al., 2000). Some doubt remains whether these 
chromodomains actually bind RNA. The notion that the MSL3 chromodomain (2-91) is 
sufficient for binding an oligonucleotide directly conflicts with previous findings that 
nucleotide binding is localized to residues 140-259 (Morales et al., 2005). The possibility of 
binding an RNA molecule however does not rule out that one or both may also bind a modified 
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histone tail. It is not known if the MOF or MSL3 chromodomains bind their putative targets as 
a monomer or as a dimer. 
During the course of this research the NMR structure of the MOF chromodomain was 
published by Nielsen et al. (2005). The structure, comprising residues 383-433 consists of five 
β-strands forming a β-barrel leading the authors to coin the name chromo-barrel domain. The 
barrel consists of two β-sheets of three strands with β2 spanning both sheets. β5, β2 and β1 on 
one side and β2, β3 and β4 on the other. The structure of the chromo-barrel is significantly 
different to the archetypal chromodomains of HP1 and PC. The chromo-barrel has no C-
terminal α-helix, has two extra β-strands and the chromo-box motif is located on the β3-β4 
loop, as opposed to the β2-β3 loop. The most significant difference is revealed when the MOF 
chromo-barrel and HP1 chromodomain complexed to an H3K4Me peptide are superimposed. 
β1 of the MOF chromo-barrel occupies the peptide-binding site seen in HP1 and PC, therefore 
MOF cannot bind a histone tail in a homologous manner (Nielsen et al., 2005) (Figure 1.14). 
This however does not rule out participation in peptide binding as the same situation is 
observed in chromodomain 1 of the CHD1 double chromodomain, discussed earlier (section 
1.7.2) (Flanagan et al., 2005). 
 
 
 
Figure 1.14: Superposition of the MOF chromo-barrel domain (blue) with the archetypal 
chromodomain of HP1 (red) complexed with a H3K4Me peptide (green). Figure taken with 
permission from (Nielsen et al., 2005). 
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The crystal structure of the N-terminal chromodomain of the H. sapiens MRG15 
(MORF4-related gene on chromosome 15) transcription factor to 2.2 Å resolution was 
published soon after the publication of the solution NMR structure of the D. melanogaster 
MOF (371-440) chromo barrel domain (Zhang et al., 2006). The MRG15 transcription factor is 
found in the MAF1 (MRG-associated factor 1), MAF2, and mammalian NuA4/Tip60 complex, 
which function in chromatin remodeling and transcriptional regulation (Garcia et al., 2007; 
Pardo et al., 2002). The MRG15 chromodomain is closely related to the D. melanogaster 
MSL3 (2-93) and the S. cerevisiae Eaf3 chromodomain. Like its D. melanogaster and S. 
cerevisiae homologues, the MRG15 protein is likely to bind a H3K36Me peptide via its 
chromodomain (Zhang et al., 2006). Like Eaf3 it is also likely to associate independently with 
the HDAC Sin3 and NuA4/Tip 60 HAT complexes (Cai et al., 2003; Doyon et al., 2004; 
Yochum and Ayer, 2002). The MRG15 chromodomains structure adopts a β-barrel closely 
resembling that of the MOF chromo-barrel domain, with a long C-terminal α-helix (Figure 
1.15). 
 
 
 
 
 
Figure 1.15: Crystal structure of the H. sapiens MRG15 chromo barrel domain (left) aligned 
next to the D. melanogaster MOF chromo-barrel domain (right). Figure taken from (Zhang et 
al., 2006). 
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Interestingly, like the MOF chromo-barrel domain, β1 of the MRG15 chromodomain 
occupies the peptide-binding site seen in HP1 and PC therefore the MRG15 chromodomain is 
unlikely to bind H3K36Me in a homologous manner (Figure 1.16). Binding of the methyl-
lysine is likely to involve a hydrophobic pocket formed by three aromatic residues, Tyr26, 
Tyr46, and Trp49 (Zhang et al., 2006). 
 
 
 
Figure 1.16: Structural overlay of the H. sapiens MRG15 chromo-barrel domain (red) with the 
archetypal HP1 chromo domain (yellow), the SMN Tudor domain (cyan), the Dnmt3b PWWP 
domain (green), and the D. melanogaster MOF chromo-barrel domain (magenta) demonstrating 
structural conservation. Figure taken from (Zhang et al., 2006). 
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It has been suggested that the D. melanogaster MOF (371-440) and MSL3 (2-91) 
chromodomains bind RNA (Akhtar et al., 2000). Akhtar et al. (2000) demonstrated a region of 
MOF (352-518) containing the chromo-barrel domain was responsible for RNA binding via 
electromobility shift assays using a roX1 RNA fragment. Interestingly, in a more recent study 
no RNA binding activity was attributable to the chromodomain of the closely related MYST 
HAT Esa1 (17-89), which also adopts a β-barrel fold most closely related to the SMN tudor 
domain (Shimojo et al., 2008). However, an N-terminally extended Esa1 construct (1-89) 
bound a poly(U) oligonucleotide. The solution NMR structure reveals that the N-terminal 
addition forms a β-sheet that acts as a knot for the chromo-barrel domain. Mutations within this 
N-terminal extension lost RNA binding ability and were lethal (Shimojo et al., 2008). A similar 
investigation contradicted the assertion that the D. melanogaster MSL3 chromodomain binds 
RNA (Morales et al., 2005). Morales et al. (2005) failed to identify any RNA binding 
attributable to the chromodomain itself, rather they demonstrated that RNA binding was 
localized to a basic region (140-259) between the chromodomain and the MRG domain. 
Interestingly, deletion of the MSL3 chromodomain had no visible effect upon targeting to the X 
chromosome on global acetylation of H4K16. The MSL3 chromodomain is, however important 
for dosage compensation and male viability (Buscaino et al., 2006). 
 
1.8  Thesis Objectives 
Chromodomains are members of the Tudor Royal family, sharing a conserved three β-
stranded core region and are a paradigm of how a single structural fold can evolve in diverse 
proteins to bind distinct targets. Chromodomains typically function as recognition motifs of 
methylated lysine residues in histone N-terminal tails and facilitate the translation of the histone 
code into a distinct local chromatin structure via recruiting the appropriate chromatin 
modulating machinery.  
Two subunits, the MYST HAT MOF and MSL3 of the DCC of D. melanogaster, a 
ribonucleoprotein complex associate with the two-fold transcriptional upregulation of the male 
X chromosome exhibit chromodomains. At the commencement of this research there was no 
published structural information on the MOF and MSL3 chromodomains or any direct evidence 
of what their function may be other than tentative evidence that they may bind RNA. 
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The goal of this research was therefore to investigate the structure of the two respective 
chromodomains by NMR and/or X-ray crystallography via the expression and purification of 
recombinant protein expressed in a bacterial expression system. Structural solution of the MOF 
and MSL3 chromodomains will advance our understanding of chromodomains in epigenetic 
processes, specifically in the DCC. 
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2.0 Materials and Methods 
 
2.1 Cell Lines 
The E. coli strain XL1 (ampR) from Stratagene was used for transformation and 
plasmid preparation. The E. coli strains Rosetta 2 (DE3) pLysS and BL21 (DE3) from 
Invitrogen and Novagen, respectively were used to express the recombinant protein of interest. 
 
2.2 Materials 
Chemicals and reagents, media, equipment, enzymes and their buffers, and DNA 
mentioned in the common methods section are listed below. 
 
 
Table 2.1: List of chemicals and reagents, media, enzymes and enzyme buffers, equipment, 
chromatography resin, and DNA used in the experimental procedures. 
 
    
Item Supplier 
  
Chemicals and Reagents  
  
Acrylamide:bis [37.5:1] OmniPur 
Agar BD Beckton Dickinson Co. 
Agarose OmniPur 
Ammonium sulfate Sigma-Aldrich 
Ampicillin Sigma-Aldrich 
β-mercaptoethanol Sigma-Aldrich 
Bromophenol blue Sigma-Aldrich 
Bovine serum albumin Sigma-Aldrich 
13C-D-glucose CIL Cambridge Isotope Laboratories 
2-(Cyclohexylamino)ethanesulfonic acid Sigma-Aldrich 
Chloramphenicol Sigma-Aldrich 
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Coomassie brilliant-blue R250 Sigma-Aldrich 
Dithiothreitol Sigma-Aldrich 
Ethylenediaminetetraacetic acid Sigma-Aldrich 
Ethanol Sigma-Aldrich 
Ethidium bromide Sigma-Aldrich 
Glacial acetic acid EMD 
Glutathione Sigma-Aldrich 
Glycerol Sigma-Aldrich 
Glycine Sigma-Aldrich 
L-Isoleucine General Biochemicals 
L-Leucine Sigma-Aldrich 
L-Lysine General Biochemicals 
L-Phenylalanine ICN Biochemicals 
L-Seleno-Methionine Sigma-Aldrich 
L-Threonine Nutritional Biochemicals Corp. 
L-Valine General Biochemicals 
Magnesium acetate Sigma-Aldrich 
Magnesium sulfate Sigma-Aldrich 
Methanol Sigma-Aldrich 
15N-Ammonium chloride CIL Cambridge Isotope Laboratories 
Phenylmethylsulphonyl fluoride Sigma-Aldrich 
Potassium acetate Sigma-Aldrich 
Potassium chloride Sigma-Aldrich 
Potassium iodide Sigma-Aldrich 
Potassium phosphate (mono-basic) Sigma-Aldrich 
Sodium Dodecyl Sulfate Sigma-Aldrich 
Sodium acetate Sigma-Aldrich 
Sodium bromide Sigma-Aldrich 
Sodium chloride Sigma-Aldrich 
Sodium phosphate (di-basic) Sigma-Aldrich 
Tris(2-carboxyethyl)phosphine hydrochloride Sigma-Aldrich 
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Tris-acetate Sigma-Aldrich 
Triton X-100 Sigma-Aldrich 
Trizma base Sigma-Aldrich 
Tryptone BD Beckton Dickinson Co. 
Yeast Extract BD Beckton Dickinson Co. 
    
  
Media  
  
Agar BD Beckton Dickinson Co. 
Tryptone BD Beckton Dickinson Co. 
Yeast Extract BD Beckton Dickinson Co. 
    
  
Enzymes and Enzyme Buffers  
  
10X Buffer Tango Fermentas 
10X DNA Ligase buffer Fermentas 
BamHI Fermentas 
BglII Fermentas 
EcoRI Fermentas 
Pfu DNA polymerase Fermentas 
SalI Fermentas 
Taq DNA polymerase Fermentas 
Trypsin Sigma-Aldrich 
    
  
Equipment  
  
Äkta FPLC Amersham Biosciences 
Äkta Prime Amersham Biosciences 
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Pipettes Gilson 
Agarose gel apparatus Owl Separation Systems 
Mighty Small II SDS PAGE apparatus Amersham Biosciences  
Power supply (model 300)  VWR 
    
  
Resin  
  
SourceQ Anion exchange resin Amersham Biosciences 
SourceS Cation exchange resin Amersham Biosciences 
Glutathione Sepharose 4B  Amersham Biosciences 
    
  
DNA  
  
D. melanogaster MSL3 and MOF cDNA  
 
Prof. Scott, M. J., Massey University, 
Palmerston North, New Zealand. 
H. sapiens MSL3 and MOF cDNA 
 
Dr. Edwin Smith, Stowers Institute for 
Medical Research, Kansas City 
Synthetic oligonucleotides Sigma-Aldrich 
    
 
 
 
2.3 Common Methods 
 
2.3.1 Agarose Gel Electrophoresis  
DNA samples were mixed with a final concentration of 1X DNA loading buffer (0.04% 
[w/v] bromophenol blue, 5% [v/v] glycerol) from a 10X stock solution. 10-20 µL was then 
loaded onto a 2-5% agarose gel. The agarose gel consisted of 2-5% w/v agarose in 1X TAE (40 
mM Tris-acetate, 1 mM EDTA, pH 8.0) from a 50X stock, and 0.5 µg/mL ethidium bromide. 
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The DNA samples were resolved on the agarose gel at 100 V for 10-20 min in 1X TAE. Bands 
were visualized using a UV lamp at 365 nm. 
 
2.3.2 SDS Polyacrylamide Gel Electrophoresis 
Protein samples were mixed with a final concentration of 1X Laemmli loading dye (80 
mM Tris-HCl, pH 6.8, 2% [w/v] SDS, 10% [v/v] glycerol, 0.2 µg/mL bromophenol blue, 5% 
[v/v] β-mercaptoethanol). 10-20 µL was then loaded onto a 4% stacking SDS polyacrylamide 
gel (150 mM Tris-HCl, pH 6.8, 0.1% [w/v] SDS, 4% [v/v] 40% acrylamide:bis [37.5:1], 0.5% 
[v/v] APS, 0.1% [v/v] TEMED) with a 17% resolving SDS polyacrylamide gel (450 mM Tris-
HCl, pH 8.8, 0.1% [w/v] SDS, 17% [v/v] 40% acrylamide:bis [37.5:1], 0.5% [v/v] APS, 0.05% 
[v/v] TEMED). All gels consisted of a 4% stacking gel and a 17% resolving gel. The protein 
samples were resolved on the SDS polyacrylamide gel at 20 mA in Tris-Glycine Laemmli 
running buffer (25 mM Tris-HCl, 200 mM glycine, 0.1% [w/v] SDS) until the dye band had run 
off. Bands were visualized by soaking the gel in a Coomassie staining solution (40% [v/v] 
methanol, 10% [v/v] glacial acetic acid, 0.1% [w/v] Coomassie brilliant-blue R250) followed 
by soaking in a destain solution (40% [v/v] methanol, 10% [v/v] glacial acetic acid). 
 
2.3.3 PCR amplification 
In order to clone the gene fragment of interest, it was first amplified by PCR. The PCR 
reaction solution contained 1X reaction buffer (200 mM Tris-HCl, pH 8.8, 100 mM (NH4)2SO4, 
100 mM KCl, 1% [v/v] Triton X-100, 1 mg/mL BSA, 20 mM MgSO4), 200 µM dNTPs, 200 
nM 5’ primer, 200 nM 3’ primer, 1 µL Pyrococcus furiosus (Pfu) DNA polymerase and 
approximately 1 ng of template DNA. The template was amplified via thirty cycles using a 
BioRad MyCycler thermal cycler (Figure 2.1). Primers are shown in Table 2.2. 
 
2.3.4 Ethanol Precipitation of PCR DNA 
To 100 µL of PCR product, 10 µL of sodium acetate (3 M, pH 5) was added followed 
by 300 µL of 95% ethanol. After storage at -20°C for 10 min, the sample was then centrifuged 
at 17418 x g (rmax,12000 rpm, Beckman JA-20 rotor) for 10 min at 4°C to pellet the DNA. The 
supernatant was discarded and the pellet washed with 200 µL of 70% ethanol. The pellet was 
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dried by rotary-evaporation and redissolved in 20 µL of TE buffer (10 mM Tris-HCl, pH 7.5, 1 
mM EDTA). 
 
2.3.5 Restriction Endonuclease Digestion 
The DNA sample to be digested was first quantified approximately by running a known 
volume on an agarose gel (described in section 2.3.1) along with DNA ladder markers of 
known size and concentration and comparing their relative intensities by ethidium bromide 
fluorescence. A reaction mixture containing 2X buffer Tango (3.3 mM Tris-acetate, pH 7.9, 1 
mM magnesium acetate, 6.6 mM potassium acetate, 0.01 mg/mL BSA), sample DNA and 0.1 
µL (one unit) of the appropriate restriction endonuclease (10 units/µL) per µg of sample DNA 
was incubated for one hour at 37oC. 
 
 
 
 
 
 
Figure 2.1: Polymerase chain reaction protocol used for amplification of the specific segment 
of DNA required. Time is shown in minutes. Stage 1 is followed by thirty cycles of stage 2, and 
then held indefinitely at 4° during stage 3. 
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Table 2.2: Primers for cloning the H. sapiens MOF and MSL3, S. pombe SWI6, and D. 
melanogaster MOF and MSL3 chromodomains. The restriction endonuclease site is shown in 
red and the stop codon in blue. The forward primer is listed first, the reverse primer second. 
The D. melanogaster MOF and MSL3 chromodomains were cloned by Joanne Guenther 
(University of Saskatchewan) and Bradley McClellan (Massey University), respectively. Ewa 
Kerc (University of Saskatchewan) contributed to the cloning of S. pombe SWI6 and H. sapiens 
MOF and MSL3 chromodomains. 
 
       
Species   Sequence 
Restriction 
Endonuclease 
   
D. melanogaster   
MOF (371-440) 5' GAC CTG GGA TCC CAA AAG ATC GAT ATA AGC GAA AAT CCC BamHI 
 5' GAC GAG GAA TTC CTA GCC CAA GTC ATC CGC ATT GTC EcoRI 
MSL3 (2-96) 5' GAC CTG GGA TCC ACG GAG CTA AGG GAC GAG ACA BamHI 
 5' GAC GAG GAA TTC CTA ACC ACG AAT TTG CAG CTT GGC EcoRI 
MSL3 (2-91) 5' GAC CTG GGA TCC ACG GAG CTA AGG GAC GAG ACA BamHI 
 5' GAC GAG GAA TTC CTA CTT GGC AGC TTC GGC CAG EcoRI 
       
    
H. sapiens    
MOF (21-93)  5' GCC GAG GGA TCC GGC GAG CCG GAA GTC ACG BamHI 
 5' GAG GCC GTC GAC CTA CTT CTG TAC AGC ATC CTT CAC TGT SalI 
MSL3 (2-93)  5' GAC CTG GGA TCC AGC GCG AGC GAG GGC ATG AAA TTT BamHI 
 5' GAC GAG GAA TTC CTA GCG AGC TAC AGC TTT TCT TGC CAA EcoRI 
       
    
S. pombe    
SWI6 (77-135) 5' GAC CTG GGA TCC GAA GAG GAT GAA TAT GTT GTA GAA AAG BamHI 
 5’ GAC GAG GAA TTC TCA CGC CTC GTT CGC CAG EcoRI 
       
    
 
 
 
2.3.6 Agarose Gel Purification of DNA 
DNA was purified by loading onto a 1-5% agarose gel (lower percentage for larger 
fragments) and resolved as previously described (section 2.3.1). The band corresponding to the 
PCR amplified fragment was then excised from the gel in the smallest amount of agarose 
possible and weighed. The DNA was extracted from the agarose using the Qiagen Gel 
Extraction Kit, following the instructions contained. The DNA was eluted with 30 µL of TE 
buffer. 
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2.3.7 DNA Ligation 
The cloned fragment of interest was PCR amplified and along with the desired vector 
individually digested with the appropriate restriction endonucleases and gel-purified as 
described earlier (section 2.3.5-6). The ligation of the insert and vector was carried out in the 
smallest volume possible, typically 10 µL containing 2 µL vector, 1 µL insert (at a 4:1 
insert:vector molar ratio), 1 µL T4 DNA ligase, 2 µL 5X reaction buffer, and 4 µL double-
distilled H20 (ddH2O). The reaction was allowed to incubate at room temperature 
(approximately 26oC) overnight (O/N). 
 
2.3.8 Competent Cells 
Competent cells were prepared by inoculating 5 mL of LB with a single XL1 colony 
and incubated at 37°C O/N. 100 mL of sterile LB was then inoculated with 1 mL of the O/N, 
and grown until an OD(600nm) of 0.6 was reached. Cells were then harvested by centrifugation at 
7741 x g (rmax, 8000 rpm, Beckman JA-20 rotor) for 10 mins. Keeping the cells on ice at all 
times, the cells were resuspended in 20 mL of ice-cold 100 mM MgCl2 solution and incubated 
on ice for 20 min. The cells were then harvested by centrifugation at 7741 x g and resuspended 
in 2 mL of a 100 mM CaCl2, 14% glycerol solution. The cells were immediately snap-frozen in 
100 µL aliquots and stored at -80°C. The transformation efficiency of the competent cells, 
expressed as the number of colonies obtained from 1 µg of DNA, was approximately 1 x 106 
cells/µg DNA. 
 
2.3.9 Transformation of Escherichia coli cell lines 
The 10 µL DNA ligation reaction or 1-2 µL of dilute recombinant plasmid was added to 
50 µL of competent E. coli XL1 cells. The cells were then cold-shocked by placing on ice for 
45-60 min and then plated onto pre-warmed (37°C) LB agar plates with ampicillin (100 
µg/mL). The plates were then incubated at 37°C O/N. 
For the transformation of expressing strains, 1-2 µL (approximately 20 ng) of the 
appropriate plasmid was added to 50 µL of competent E. coli Rosetta 2 cells. The cells were 
then cold-shocked by placing on ice for 45-60 min and then plated onto pre-warmed (37°C) LB 
agar plates with ampicillin (100 µg/mL) and chloramphenicol (34 µg/mL). 
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2.3.10 Recombinant Screening 
Colony PCR was employed to screen recombinant colonies using PCR primers used to 
amplify the respective inserts. A PCR reaction was set up identically to the cloning PCR 
reaction but using Thermus aquaticus (Taq) polymerase and its respective buffer. Instead of 
template DNA the reaction mixture was inoculated with a colony from the transformation agar 
plate. Care was taken not to remove the entire colony. A separate reaction was set up for each 
colony. A standard PCR cycle was run and 5 µL of each reaction, mixed with 5 µL of 2X DNA 
loading buffer, was loaded on a 1% agarose gel. The cloned PCR insert was loaded as a control. 
A band exactly the same size as the control was observed for positive colonies. Positive 
colonies were re-streaked onto separate ampicillin agar plates. 
 
2.3.11 Plasmid Preparation 
For positive colonies, 5 mL of LB broth containing 100 µg/mL ampicillin was 
inoculated with a separate colony and grown O/N at 37°C with shaking. The cells were 
harvested by centrifugation at 15008 x g (rmax, 10,000 rpm, Beckman JLA-16.250 rotor) for 1 
min. The supernatant was discarded. The cells were lysed and the plasmid purified using the 
Qiagen Plasmid Mini-Prep kit, following the instructions contained within. To verify the 
correct insert, approximately 1 µg of the respective plasmid was single and double restriction 
digested and run on an agarose gel with digested vector and insert as controls. The single cut 
plasmid should yield one band running slower than cut vector, while the double cut plasmid 
should yield two bands equal in size to the cut vector and the insert, respectively. The inserts 
were also sequenced at the Plant Biotechnology Institute DNA sequencing facility at the 
University of Saskatchewan for further confirmation. 
 
2.3.12 Expression of Recombinant Protein 
Recombinant protein was expressed in Rosetta 2 E. coli cells (Invitrogen). A 5 mL 
aliquot of LB containing 100 µg/mL ampicillin and 34 µg/mL chloramphenicol was inoculated 
with a single colony and grown O/N at 37°C. A 6 L flask containing 2 L of LB containing the 
appropriate antibiotics was then inoculated with 1 mL of the O/N and grown to the appropriate 
optical density (OD600nm) at 37°C. The cells were then induced with 0.1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) and either grown at 37°C or 25°C O/N, depending upon the 
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Table 2.3: Expression conditions for the S. pombe SWI6, H. sapiens and D. melanogaster MOF 
and MSL3 chromodomains. Induction with 0.1 mM IPTG followed by incubation at 25°C for 
16 hr was optimal for all constructs. 
 
    
Species OD 
D. melanogaster  
MOF (371-440) 0.2 
MSL3 (2-96) 0.6 
MSL3 (2-91) 0.6 
    
  
H. sapiens  
MOF (20-93)  0.6 
MSL3 (2-93) 0.8 
    
  
S. pombe  
SWI6 (77-135) 0.8 
    
  
 
 
optimal expression conditions determined for that recombinant protein. Optimal conditions are 
summarized in Table 2.3. 
 
2.3.13 Cell Lysis and GST Affinity Purification 
The Pharmacia Biotech pGEX-6P3 vector expression vector was used, which is an 
IPTG inducible expression vector. The insert is incorporated downstream of the glutathione S-
transferase (GST) gene, therefore the recombinant protein is expressed as a GST chimera 
allowing for GST affinity chromatography using Glutathione Sepharose 4B (Amersham 
Biosciences) (Figure 2.2). 
After induction with IPTG and incubation, the cells were harvested by centrifugation at 
7741 x g (rmax, 8,000 rpm, Beckman JA-20 rotor) for 10 min, and resuspended in 50 mL of cold 
lysate buffer (PBS [140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.3], 
50 µM PMSF, 0.1% v/v β-mercaptoethanol, 1 mM EDTA). The cells were stored at -20°C until 
ready for lysis. Cells were thawed and kept on ice preceding lysis by French-press. The lysate 
was immediately centrifuged at 12096 x g (rmax, 10,000 rpm, Beckman JA-20 rotor) at 4°C for
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Figure 2.2: Map of the pGEX-6P3 expression vector and the multiple cloning site. Map taken 
from http://www6.gelifesciences.com. 
 
45 min. The supernatant was then decanted from the pellet and loaded, at 4°C, onto a column 
packed with Glutathione Sepharose 4B (Amersham Biosciences) using an Äkta prime system 
(Amersham Biosciences). The column, stored at 4°C in 20% ethanol, was washed prior to 
loading with ddH2O followed by lysate buffer. Lysate buffer was used as the running buffer. 
After the supernatant was loaded, the bound protein was washed with three times the volume of 
supernatant loaded prior to elution of the GST chimera with elution buffer (10 mM reduced 
glutathione, 50 mM Tris-HCl, 150 mM NaCl, pH 8). Addition of NaCl is not typically 
prescribed but its addition was found to solve some solubility issues. Addition of NaCl appears 
to broaden the elution profile of the GST chimeric protein. The eluted protein was analyzed by 
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SDS-PAGE. The protein was then dialyzed into 1 L of cleavage buffer (50 mM Tris-HCl, 150 
mM NaCl, 1 mM DTT, 1 mM EDTA, pH 8.0) prior to removal of the GST tag via PreScission 
protease (Amersham Biosciences) cleavage at 4°C O/N. Dialysis was carried out in two 1 L 
steps to remove the majority of the glutathione. After dialysis, the cleaved GST was removed 
by loading the protein back onto the Glutathione Sepharose 4B column, the GST binds and the 
cleaved protein of interest is eluted. Removal of GST was analyzed by SDS-PAGE. 
 
2.3.14 Anion, Cation, and Size Exclusion Chromatography 
 
2.3.14.1 Anion and Cation Exchange Chromatography 
After GST affinity chromatography, the respective proteins were further purified by ion 
exchange chromatography. The use of cation or anion exchange was determined based upon the 
proteins theoretical pI, calculated from its amino acid sequence. The chromodomain was 
dialyzed into 2 L of its respective buffer. The buffer used for each chromodomain protein, its pI 
and the buffer’s pH are summarized in Table 2.4. The buffer was typically 50 mM buffer, 150 
mM NaCl, and 5 mM DTT. The protein was dialyzed for approximately twelve hours followed 
by dialysis into 2 L of running buffer containing 50 mM buffer, 5 mM DTT (Buffer A). Buffer 
B is identical with the exception that it contains 1 M NaCl, and is used for elution of the bound 
protein from the column. Using an Äkta FPLC system (Amersham Biosciences), the protein 
was then loaded onto the appropriate ion exchange column at a flow rate of 1 mL/min 
(Amersham Biosciences). The column, stored at 4°C in 20% ethanol, was washed prior to 
loading with three column volumes (30 mL) ddH2O followed by three column volumes of 
buffer A. The bound protein was washed with three times the volume of the sample loaded with 
buffer A, prior to elution with a buffer B. The protein was eluted from the column with buffer 
B, over two column volumes, at a 50% gradient (Figure 2.3). The eluted protein was analyzed 
by SDS-PAGE. 
 
2.3.14.2 Size Exclusion Chromatography (SEC) 
After anion or cation exchange, the purified protein was concentrated using Millipore 
Amicon Ultra 5k Dalton cut-off centrifugal filter devices to approximately 1.5 mL. A 500 µL 
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Table 2.4: Summary of the Chromodomains Ion Exchange. Summary of the expressed 
chromodomain proteins pI, the type of ion exchange chromatography employed and the pH of 
the running buffer used. 
 
        
Protein pI Ion Exchange Buffer A pH 
    
D. melanogaster    
MOF(371-440) 5.84 cation Sodium Acetate  5.0 
  anion Tris.HCl 8.0 
MSL3 (2-96) 8.97 cation Sodium Acetate 5.5 
MSL3 (2-91) 8.60 cation Sodium Acetate 5.5 
      
     
H. sapiens     
MOF (20-93)  5.31 anion Tris.HCl 8.0 
MSL3 (2-93) 9.72 cation Bis-Tris-propane 6.5 
      
     
S. pombe     
SWI6 (77-135) 4.52 anion Tris.HCl 8.0 
     
    
 
 
Figure 2.3: Ion exchange chromatography profile. A typical profile used for anion or cation 
exchange chromatography showing the loading (red), washing (green), elution gradient 
(orange), and regeneration (purple) stages. 
R
egeneration 
      Elution 
        W
ash 
    Loading 
Volume mL 
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aliquot was then loaded onto a Superdex 75 10/300 GL (Amersham Biosciences) size exclusion 
column, pre-equilibrated in PBS containing 5 mM DTT, at a flow rate of 0.5 mL/min. Care was 
taken to not let the pressure exceed 1 MPa. The eluted peak was analyzed by SDS-PAGE. 
 
2.3.15 Isotopic labeling of the D. melanogaster MOF and MSL3 
Chromodomains 
To investigate the structure of the D. melanogaster MOF and MSL3 chromodomains by 
nuclear magnetic resonance 15N and 13C isotopically labeled protein was prepared (Marley et 
al., 2001). A 5 mL aliquot of LB containing 100 µg/mL ampicillin, inoculated with a single E. 
coli BL21 colony transformed with approximately 20 ng of either the recombinant MOF or 
MSL3 plasmid, was incubated at 37°C O/N. Two liters of LB containing 100 µg/mL ampicillin, 
was inoculated with 1 mL of the O/N and incubated with shaking at 37°C until an OD(600nm) 
was reached. Under sterile conditions, the cells were harvested by centrifugation at 7741 x g 
(rmax, 8,000 rpm, Beckman JA-20 rotor) for 10 min, and washed (3 x 50 mL) with warm (37°C) 
M9 minimal medium (22 mM KH2PO4, 90 mM Na2HPO4, 8 mM NaCl, 22 mM D-glucose, 2 
mM MgSO4, 0.1 mM CaCl2). After washing, the cells were resuspended and added to 1 L M9 
minimal medium containing either 1 g/L 15NH4Cl or 1 g/L 13C-D-Glucose. After incubating 
with shaking at 37°C for 20-30 mins, the temperature was reduced to 25°C, the cells were 
induced with 0.1 mM IPTG and incubated O/N. The cells were subsequently harvested and 
lysed, as described above (section 2.3.13). The isotopically labeled protein was purified by ion 
exchange and SEC, as described above (2.3.14). Dr. Hideo Iwai (University of Saskatchewan) 
measured the 1H-15N and 1H-13C heteronuclear single quantum coherence (HSQC) Spectra at 
the Saskatchewan Structural Sciences Centre (SSSC) on the Bruker 500 MHz Avance NMR 
spectrometer. 
 
2.3.16 Site-Directed Mutagenesis 
 
2.3.16.1 Site-Directed Mutagenesis of the D. melanogaster MOF 
Chromodomain 
The absence of a Met residue in the D. melanogaster MOF chromodomains meant that 
one had to be engineered into the protein before a seleno-methionine (Se-Met) derivative could 
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be prepared. A total of nine mutants were made, summarized in Table 2.5, using the Stratagene 
QuickChange II Site-Directed Mutagenesis Kit and following the instructions contained therein. 
Mutant plasmid was prepared as described above (section 2.3.11) and the mutation was 
confirmed by DNA sequencing. 
 
 
Table 2.5: Summary of the D. melanogaster MOF chromodomain methionine mutations. The 
mutated codon is shown in bold. The forward primer is listed first, the reverse primer second. 
 
 
     
Mutant  DNA Sequence 
   
Ile385Met 5' CCC GAC AAG ATC TAT TTT ATG CGG CGC GAG GAT GGC ACC GTG 
 5' CAC GGT GCC ATC CTC GCG CCG CAT AAA ATA GAT CTT GTC GGG 
   
Ile432Met 5' GGA TGG GTG GGC AGG CAT AGG ATG TCG GAC AAT GCG GAT GAC TTG GGC 
 5' GCC CAA GTC ATC CGC ATT GTC CGA CAT CCT ATG CCT GCC CAC CCA TCC 
   
L398Met 5' CGT GGC CAG GTG ATG CAG TCT CGC ACC ACT GAG AAT GCG 
 5' CGC ATT CTC AGT GGT GCG AGA CTG CAT CAC CTG GCC ACG 
   
Leu419Met 5' C GTC CAC TAT GTT GGT ATG AAT CGC CGC CTG GAC GG 
 5' CC GTC CAG GCG GCG ATT CAT ACC AAC ATA GTG GAC G 
   
Leu423M 5' GGT CTC AAT CGC CGC ATG GAC GGA TGG GTG GGC AGG 
 5' CCT GCC CAC CCA TCC GTC CAT GCG GCG ATT GAG ACC 
   
Val397Met 5' CC GTG CAC CGT GGC CAG ATG CTT CAG TCT CGC 
 ' GCG AGA CTG AAG CAT CTG GCC ACG GTG CAC GG 
   
Val414Met 5' GCC GCT CCC GAT GAG TAC TAC ATG CAC TAT GTT GG 
 5' CC AAC ATA GTG CAT GTA GTA CTC ATC GGG AGC GGC 
   
Val427Met 5' CGC CTG GAC GGA TGG ATG GGC AGG CAT AGG 
 5' CCT ATG CCT GCC CAT CCA TCC GTC CAG GCG 
   
Ile327Met 5' CCC CTG GGA TCC CAA AAG ATG GAT ATA AGC GAA AAT CCC 
 5' GGG ATT TTC GCT TAT ATC CAT CTT TTG GGA TCC CAG GGG 
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2.3.16.2 Site-Directed Mutagenesis of the D. melanogaster MSL3 
Chromodomain 
During ion exchange and SEC, it was observed that the D. melanogaster MSL3 
chromodomain forms oxidized cysteine oligomers (discussed in greater detail in section 3.2.1). 
A reducing agent was added at every stage of the purification right from lysis. DTT was 
typically used, though due to its relative instability (it spontaneously oxidizes to form a six-
member ring with an internal disulfide bond) it is not suitable for use in crystallization screens 
due to the relatively long period of time required for protein nucleation and crystallization. To 
maintain the D. melanogaster MSL3 chromodomain (2-91) in its reduced monomeric form, the 
reducing agent Tris(2-carboxyethyl)phosphine HCl (TCEP hydrochloride) was added to the 
crystallization buffer. Despite TCEP’s relative stability, it still does not ensure that the protein 
is not oxidizing, which in theory would be an obstacle to crystallization as the protein is no 
longer homogeneous. To address this issue, mutation of Cys66, one of the two cysteine 
residues, was investigated. The other Cys residue (Cys19) is part of the hydrophobic core, and 
is therefore unlikely to be solvent exposed. Primers were designed for mutagenesis of the Cys 
residue to Ser, due to the conserved nature of the mutation, using the Stratagene QuickChange 
II Site-Directed Mutagenesis Kit (Table 2.6). 
 
 
Table 2.6: Primers used in the site-directed mutagenesis of C66 to Serine using the Stratagene 
QuickChange II Site-Directed Mutagenesis Kit. The mutated codon is shown in bold. The 
forward primer is listed first, the reverse primer second. 
 
 
    
Mutant  DNA Sequence 
   
C66S 5' CGT CCA TCC TAC GAT CGC AGT GTG CGC GCC ACC 
 5' GGT GGC GCG CAC ACT GCG ATC GTA GGA TGG ACG 
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2.3.17 Incorporation of Se-Met into Met Mutant D. melanogaster MOF  
A 5 mL aliquot of LB containing 100 µg/mL ampicillin, inoculated with a single BL21 
colony transformed with the desired Met mutant MOF plasmid, was incubated at 37°C O/N. 
Two liters of LB containing 100 µg/mL ampicillin was inoculated with 1 mL of the O/N and 
incubated with shaking at 37°C until an OD(600nm) of 0.6 was reached. Under sterile conditions 
the cells were harvested by centrifugation at 7741 x g (rmax, 8,000 rpm, Beckman JA-20 rotor) 
for 10 min, and washed (3 x 50 mL) with warm (37°C) M9 minimal medium. The cells were 
then washed a final time with 50 mL of M9 minimal medium containing amino acids (100 
mg/L L-Lys, 100 mg/L L-Thr, 100 mg/L L-Phe, 50 mg/L L-Val, 50 mg/L L-Leu, 50 mg/L L-
Ile) to inhibit endogenous Met synthesis. After washing, the cells were resuspended and added 
to 1 L M9 minimal medium containing the above amino acids and 60 mg/L L-seleno-
methionine (Se-Met). After incubating with shaking at 37°C for 20-30 mins, the temperature 
was reduced to 25°C and the cells were induced with 0.1 mM IPTG and incubated O/N. The 
cells were subsequently harvested and lysed as described above (section 2.3.13). The Se-Met 
MOF was purified by anion exchange and SEC as described above (section 2.3.14). 
 
2.3.18 Limited Proteolysis 
Approximately 0.1 mg of trypsin was dissolved in 1 mL of 10% glycerol and PBS and 
its molar concentration determined by UV(280nm) spectroscopy. Trypsin was added to the 
recombinant protein of interest at a molar ratio of 1:1000. The protease digestion was allowed 
to proceed at room temperature over an hour with 5 µL samples taken at 5, 10, 20, 40, and 60 
min. The reaction was stopped via the immediate addition of 1 µL of 200 µM PMSF and 5 µL 
SDS loading dye prior to boiling for 1 min (Lane et al., 2006). The protease-digested samples 
were then analyzed by SDS-PAGE. 
 
2.3.19 Vapour Diffusion Crystallization Screens 
The crystallization of a macromolecule by vapour diffusion involves the suspension of a 
droplet containing protein, buffer and precipitant over a reservoir containing the precipitant at a 
higher concentration. The difference in precipitant concentration causes diffusion of water 
vapor from the droplet into the reservoir, which ideally results in the protein concentration in 
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the droplet becoming super-saturated and the protein crystallizing. The protein drop was 
suspended on a plastic microscope coverslip and suspended over a single well of a 24 well 
tissue culture tray. The well was sealed with vacuum grease. 
Initial crystallization screens of the D. melanogaster MOF and MSL3, H. sapiens MOF, 
and Schizosaccharomyces pombe SWI6 chromodomains used the Emerald Biosciences Wizard 
I and II and Hampton Research Crystal Screen I and II commercial sparse matrix screens. 
D. melanogaster MOF chromodomain crystals were initially identified growing in 
condition 16 of the Emerald Biosciences Wizard II screen, which contained 1 M sodium citrate 
and 100 mM CHES pH 9.5. Citrate concentration and pH were subsequently screened to 
optimize crystal size. Optimal conditions for the growth of large crystals was around 1 M 
sodium citrate, 10% glycerol (v/v), and 100 mM CHES, pH 9.2. 
 
2.3.20 Iodide and Bromide Crystal Soaking 
In an attempt to incorporate an anomalous scatterer (iodide [I-] or bromide [Br-]) into 
the crystal lattice to attain an anomalous signal, native crystals were soaked in a cryo-solution 
containing 500 mM NaBr or 500 mM KI, 1.5 M sodium citrate, 100 mM CHES, pH 9.5 for 20-
40 sec. The increased sodium citrate concentration and pH, compared to the crystallization 
conditions stated above, is required to prevent the crystals from dissolving. The crystal was 
then immediately mounted on the goniostat and frozen in a stream of nitrogen at 114 K. 
 
2.3.21 X-ray Diffraction Experiments 
Initial diffraction experiments of the native recombinant D. melanogaster MOF 
chromodomain (371-440) crystals and iodide-soaked crystals were carried out at the 
Saskatchewan Structural Sciences Centre using a DX8 Proteum rotating Copper (Cu) anode 
diffractometer with a Kappa goniostat and Proteum 4K charge-coupled device (CCD) detector. 
Crystals were diffracted under a stream of nitrogen at 114 K using a Kryoflex low temperature 
apparatus. The diffraction images were processed using SaintPlus and ProScale (Bruker AXS 
Inc), and HKL2000 (Otwinowski and Minor, 1997). 
A native data set was kindly collected by Prof. Louis Delbaere’s Laboratory (University 
of Saskatchewan) at the Advanced Photon Source on the BioCARS 14 BM-C beamline, using a 
ADSQ Quantum 315 detector. Crystals were diffracted under a stream of nitrogen at 105 K. 
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The diffraction images were processed using the HKL2000 software package (Otwinowski and 
Minor, 1997). 
Diffraction of Se-Met D. melanogaster MOF L423M mutant crystals, native crystals, 
and native crystals soaked in an iodide or bromide cryo-solution was carried out at the 
Canadian Light Source (CLS) on the Canadian Macromolecular Facility 1 (CMCF1) 08ID-1 
beamline using a MAR225 Detector. The diffraction images were processed using the 
HKL2000 (Otwinowski and Minor, 1997) software package. 
 
2.3.22 Phase Determination 
A photon has both amplitude, which is proportional to the square root of the intensity, 
and phase. In a diffraction experiment, only the intensity of the diffracted photon is measured 
since the relative phase information is lost. Determination of the phases by either experimental 
or theoretical methods is essential to the solution of an X-ray crystal structure. Central to 
solution of the phase problem is the Patterson map (Figure 2.4). 
In crystallography the electron density map is calculated via an inverse Fourier 
transform of the structure factors (amplitude and phase). The Patterson map is the Fourier 
transform of the squared amplitudes. Peaks in the Patterson map represent vectors between 
atoms. There are three types of peaks in the Patterson map arising from intramolecular vectors, 
intermolecular vectors, and self-vectors. A vector has both direction and magnitude (or length).  
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Argand diagram depicting a structure factor, its phase (α[hkl]) and its magnitude 
(|F[hkl]|). The equation for the calculation of the electron density (ρ [xyz]) is the sum of the 
structure factor amplitudes and phases. 
α(hkl) 
|F(hkl)| 
F(hkl) 
i 
real 
ρ (xyz)=1/V Σ Σ  Σ |F(hkl)|e-2πi(hx+ky+lz) + iα(hkl)                                                                                                                   h   k   l 
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Self-vectors are vectors between an atom and itself and therefore have no magnitude, therefore 
giving rise to a large peak at the origin of the Patterson map. Intramolecular vectors will be 
shorter than intermolecular vectors and will therefore give rise to a peak closer to the origin of 
the Patterson map. The height of a peak in the Patterson map is directly proportional to the 
number of electrons of a given atom, therefore the heavier the atom the larger the peak in the 
Patterson map. The original position of the atoms can be directly calculated from the Patterson 
map for small molecule crystals. Solution of the Patterson map becomes increasingly difficult 
as the number of atoms increases, which directly correlates to the number of peaks within the 
Patterson map increasing. The large number of atoms in a protein molecule makes ab initio 
solution of the Patterson map practically impossible. 
 
2.3.22.1 Molecular Replacement: PHASER 
The molecular replacement software, PHASER (McCoy et al., 2007), was employed 
initially to determine phases for the diffraction amplitudes of the D. melanogaster MOF 
chromodomain crystals, using the solution NMR structure published during the course of this 
research (Nielsen et al., 2005)(PDB 2bud). The 2bud.pdb file is an ensemble of 25 conformers 
of residues 367-454. Based upon superposition of the ensembles members, the search model 
was truncated to residues 378-443 to remove disordered or heterogenous regions. Single 
conformers along with the entire ensemble were used in separate searches with and without the 
side-chains truncated to the β-carbon atom. 
To calculate phases from the model, the model needs to be correctly positioned into the 
crystal unit cell to approximate the structure that we are trying to solve. Three rotation angles 
and three translational distances define the models position. The intramolecular vectors of the 
Patterson map are defined by the orientation of the molecule only and not its position in the 
cell. Therefore the model can be oriented properly by using data from the Patterson map close 
to the origin. Once a rotation solution(s) has been found, the intermolecular data from the 
Patterson map is used to translate the model into its correct position in the unit cell. 
PHASER sequentially carries out an anisotropy correction of the diffraction data, cell 
content analysis, a rotation function to orientate, and a translation function to position the 
model in the unit cell, using maximum likelihood methods. Molecular replacement basically 
measures the correlation between the Patterson function calculated from the diffraction data and 
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the Patterson function calculated from the model. The likelihood function is a probability 
measuring the agreement between the two. A high probability indicates that the model’s 
position and orientation within the unit cell closely approximates that of the structure to be 
resolved and phases from the model can be then calculated and used to calculate an initial 
electron density map. 
 
2.3.22.2 Single Isomorphous Replacement (SIR) 
Isomorphous replacement involves the soaking or co-crystallization of a heavy atom 
into the crystal. Data is collected separately on a native crystal and the isomorphous heavy atom 
derivative crystal. The difference in the structure factor amplitudes between the two data sets is 
due to the contribution of the heavy atom(s). The structure factor of the heavy atom derivative 
(FPH) is the vector sum of the heavy atom structure factor (FH) and the native protein atoms 
structure factor (FP). Therefore a differences Patterson map can be calculated. The peaks in the 
calculated Patterson map will theoretically only represent a vector between two heavy atoms. 
As only a few heavy atoms are incorporated, the differences Patterson map can be solved 
directly. SIR gives two trigonometrically possible values for the phase. In theory, multiple 
isomorphous replacement (MIR) (i.e. more than one derivative data sets) gives only one 
possible phase. In reality, compound errors and approximations give rise to a phase probability 
distribution for each measured reflection.  Phase information, calculated from the position of 
the heavy atoms in the unit cell, can then be used to calculate an initial electron density map. 
 
2.3.22.3 Multi-wavelength Anomalous Dispersion (MAD) 
Friedels Law states that a reflection from a plane with Miller indices (h,k,l) will have 
identical magnitude but opposite phase as a reflection from a plane with Miller indices (-h,-k,-
l). Friedels Law is obeyed only when there is no anomalous dispersion. Anomalous dispersion 
is a phenomenon where an atom’s electrons absorb a photon of a specific wavelength and 
reemits it after a delay, with a phase shift. The anomalous scattering effect is generally more 
significant the heavier the atom, but also depends strongly on the exciting wavelength. The 
energy of a photon (E) is inversely proportional to its wavelength (λ), c is the speed of light in a 
vacuum (3x108 m/s) and h is Plancks constant (6.626x10-34 J.s). 
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E=(hc)/λ  
 
The energy of the photon that a specific element absorbs is known as that element’s 
absorption edge. In a typical MAD experiment, diffraction data is collected at three 
wavelengths; at the peak of the absorption, at the inflection point of the absorption (when the 
dispersive component is at a minimum), and at a remote wavelength where there is minimal 
anomalous dispersion. Analysis of the anomalous differences Patterson map, calculated using 
the three data sets, allows for the calculation of the anomalous scatterers position and the 
subsequent calculation of phases, analogous to MIR. 
 Multi-wavelength anomalous dispersion data from Se-Met mutant MOF crystals were 
collected at the CLS on the CMCF-1 08ID-1 beamline. A fluorescence scan was run initially to 
confirm selenium incorporation. Data was collected at the peak (12.6558 keV) and inflection 
(12.6553) points of the selenium absorption edge. Peak and inflection were chosen at the 
suggestion of the beamline scientist, although if only two wavelengths are chosen, peak and 
remote are typically used. Initial data was collected over 120° with 0.5° oscillations over 2 sec. 
Beam attenuation, oscillation, and exposure time were refined subsequently to reduce radiation 
damage. 
Single isomorphous replacement with anomalous signal (SIRAS) data is collected at a 
single wavelength, which optimally reduces exposure time and hence radiation damage to the 
data. It is similar to SIR but uses the anomalous signal to help resolve the phase ambiguity. 
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3.0 Results 
 
3.1 Purification and Isotopic Labeling of the D. melanogaster MSL3 
Chromodomain (2-96) 
The original D. melanogaster MSL3 chromodomain (2-96) construct was designed by 
Dr. S. Moore and cloned into the pGEX-6P3 expression vector by B. McClellan (Massey 
University). The theoretical pI and molecular weight (MW) of the D. melanogaster MSL3 
chromodomain (2-96), based upon the amino acid sequence is 8.97 and 11398 Da, respectively.  
When the D. melanogaster MSL3 chromodomain (2-96) GST chimera was analyzed by 
SDS-PAGE (17% acrylamide:bis [37.5:1]) after GST affinity chromatography, a large single 
band was observed at approximately 36 kDa, indicating that the construct expressed well, and 
that the purification step was successful in removing the majority of impurities. Remaining 
impurities are observed as several faint bands on the SDS-PAGE gel. The protein appeared to 
be relatively stable as no visible degradation products, such as GST, were observed (Figure 3.1 
A). When digested with PreScission protease, two fragments were observed on the SDS-PAGE 
gel, as expected, with molecular weights consistent with the MSL3 chromodomain (11 kDa) 
and GST (25 kDa) (Figure 3.1 B). After removal of the cleaved GST and further purification by 
cation exchange chromatography, the D. melanogaster MSL3 chromodomain (2-96) was 
visibly homogenous, based upon SDS-PAGE (Figure 3.1 C). 
The D. melanogaster MSL3 chromodomain was isotopically labeled with 15N and 13C as 
outlined in section 2.3.15. Dr. Hideo Iwai collected the 1H-15N and 1H-13C heteronuclear single 
quantum coherence (HSQC) spectra at the Saskatchewan Structural Sciences Centre (SSSC) on 
a Bruker 500 MHz Avance NMR spectrometer (Figure 3.2). The observation and assignment of 
multiple peaks of weak intensity in the 1H-15N HSQC spectra indicated that the last five 
residues of the C-terminus of the D. melanogaster MSL3 chromodomain (2-96) were 
undergoing rapid proton exchange, indicative of a disordered structure. The disordered section 
could prevent a solution of the structure by NMR and/or prevent the protein from crystallizing. 
Dr. S. Moore redesigned the domain, truncating the last five C-terminal residues (Figure 3.3). 
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The NMR studies were not pursued further after Dr. Hideo Iwai left the University of 
Saskatchewan. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Purification of the D. melanogaster MSL3 chromodomain (2-96). A. SDS-PAGE 
(17% acrylamide:bis [37.5:1]) of the GST D. melanogaster MSL3 chromodomain (2-96) 
purified by GST affinity chromatography using a glutathione Sepharose 4B column. Molecular 
weight (MW) markers are shown. B. SDS-PAGE of the D. melanogaster MSL3 chromodomain 
(2-96) after cleavage with PreScission protease. Molecular weight (MW) markers are shown. C. 
SDS-PAGE of the D. melanogaster MSL3 chromodomain (2-96) after cation exchange 
chromatography. Molecular weight (MW) markers are shown. 
 
 
 
3.2 D. melanogaster MSL3 Chromodomain (2-91) 
 
3.2.1 Purification of the D. melanogaster MSL3 Chromodomain (2-91) 
The truncated D. melanogaster MSL3 chromodomain (2-91) construct, designed by Dr. 
S. Moore based upon the 1H-15N HSQC findings, was cloned into the pGEX-6P3 expression 
vector. Ewa Kerc (University of Saskatchewan) contributed to the cloning, ligation, 
transformation, and plasmid purification. The theoretical pI and molecular weight (MW) of the 
D. melanogaster MSL3 chromodomain (2-91) based upon the amino acid sequence is 8.6 and 
10830 Da, respectively. SDS-PAGE (17% acrylamide:bis [37.5:1]) of the eluate after GST
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Figure 3.2: 1H-15N HSQC spectrum of the D. melanogaster MSL3 chromodomain. 
 
 
  
               1             11            21            31            41                    
               |             |             |             |             |                    
MSL3 (2-96) MTELRDETPL FHKGEIVLCY EPDKSKARVL YTSKVLNVFE RRNEHGLRFY  
MSL3 (2-91) MTELRDETPL FHKGEIVLCY EPDKSKARVL YTSKVLNVFE RRNEHGLRFY 
 
 
               51            61            71            81           91 
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MSL3 (2-96) EYKIHFQGWR PSYDRCVRAT VLLKDTEENR QLQRELAEAA KLQIRG 
MSL3 (2-91) EYKIHFQGWR PSYDRCVRAT VLLKDTEENR QLQRELAEAA K 
 
 
 
 
Figure 3.3: Sequence alignment of the two D. melanogaster MSL3 chromodomain constructs 
designed by Dr. S. Moore. The two cysteine residues in the construct are highlighted and 
underlined. 
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affinity purification revealed a large band running at approximately 36 kDa, which was 
consistent with the size of the GST-MSL3 (Figure 3.4 A). The bands observed at approximately 
25 kDa and 14 kDa, which were likely to be GST and MSL3, respectively, indicate some 
proteolysis had occurred. Other than the degradation products, no other significant bands were 
observed on the SDS-PAGE gel, indicating that the GST affinity purification was successful in 
purifying the protein from the lysate. When digested with PreScission protease, two fragments 
were observed on the SDS-PAGE gel, as expected, with molecular weights consistent with the 
MSL3 (2-91) chromodomain (approximately 10 kDa) and GST (25 kDa) (Figure 3.4 B). 
Although the MSL3 (2-91) protein is smaller than the MSL3 (2-96) protein, the difference in 
molecular weight was too small to distinguish by SDS-PAGE or SEC. DNA sequencing 
previously confirmed the correct size of the constructs. 
After GST affinity purification and PreScission protease digestion, the MSL3 (2-91) 
chromodomain was purified to homogeneity by cation exchange and size exclusion 
chromatography (SEC) (Figure 3.4 C-F). After size exclusion chromatography, the MSL3 (2-
91) chromodomain was concentrated to approximately 20 mg/mL in a total volume of 350 µL, 
a total yield of approximately 7 mg of protein from 2 L of culture. The concentration was 
calculated using Beer’s Law (Equation 3.1) and the solutions absorbance, measured at 280 nm.  
SDS-PAGE indicated that the MSL3 (2-91) chromodomain was homogenous. The observation 
of a single peak on the SEC75 chromatogram indicated that the MSL3 (2-91) chromodomain 
was present as a homogenous species (Figure 3.4 E). By measuring the retention volumes of 
proteins of known molecular weight (Table 3.1) a standard curve can be constructed using 
Equation 3.2, from which the experimental molecular weight of an unknown protein can be 
approximated (Figure 3.5). 
 
 
 
A = εlc 
 
 
Equation 3.1: Beer’s Law. A is absorbance (no units), ε is the molar absorbtivity (L/mol/cm), l 
is the path length of the sample (cm) and c is the concentration of the absorbing species in 
solution (mol/L). 
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E.  
 
 
F. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Purification of the D. melanogaster MSL3 chromodomain (2-91). A. SDS-PAGE 
(17% acrylamide:bis [37.5:1]) of the eluted GST-MSL3 after GST affinity purification. 
Molecular weight markers are shown. B. SDS-PAGE of the GST-MSL3 after cleavage with 
PreScission protease and removal of the GST by a subsequent round of GST affinity 
purification after the glutathione had been removed by dialysis. C. Cation exchange 
chromatogram of the MSL3 chromodomain. The cleaved MSL3 chromodomain was loaded 
onto a SourceS cation exchange column at 1 mL/min. The protein was bound and washed with 
buffer A (see section 2.3.13.1) prior to a gradient elution with buffer B. Absorbance (280 nm) is 
shown in blue (mAU is absorbing units x 1000), conductivity (indicating salt concentration) in 
brown (mS/cm), and concentration (percentage of buffer B) is shown in green (%B). D. SDS-
PAGE of the MSL3 chromodomain after cation exchange purification. E. Size exclusion 
chromatography of the cation exchange fractions, determined by SDS-PAGE to contain the 
MSL3 chromodomain, after pooling and concentration. 500 µL was loaded onto a Superdex 75 
column at a flow rate of 0.5 mL/min. The eluate was collected in 1 mL fractions. F. SDS-PAGE 
of the peak that eluted from the SEC75 column. 
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Equation 3.2: Definition of Kav. Kav is a constant for a specific protein of specific molecular 
weight. Ve is the elution volume of the protein, Vo the column void volume and Vt the total bed 
volume. 
 
Table 3.1: Standard curve data for construction of the Superdex 75 molecular weight standard 
curve. Data provided by Dr. M. Lane (University of Saskatchewan).  
 
 
              
       
Standard Ve Vo Vt Kav MW logMW 
              
       
Albumin 9.84 7.84 24 0.12 67000 4.826 
Ovalbumin 10.88 7.84 24 0.19 43000 4.6335 
Chymotrypsinogen 
A 12.8 7.84 24 0.31 25000 4.3979 
Ribonuclease A 13.8 7.84 24 0.37 13700 4.1367 
Aprotinin 15.73 7.84 24 0.49 6500 3.8129 
Vitamin B12 19.15 7.84 24 0.7 1355 3.1319 
              
       
 
 
Figure 3.5: Superdex 75 molecular weight calibration curve. Plot of Kav versus the log 
molecular weight of the standards. The slope of the best-fit is shown along with the regression 
score. The data was provided by Dr. M. Lane, formerly of the University of Saskatchewan. 
Kav =  
            
Ve  -   Vo 
 
Vt  -   Vo 
 
y = -0.3402x + 1.7772 
 
R2 = 0.9935 
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The theoretical molecular weight of the D. melanogaster MSL3 (2-91) chromodomain 
is 10830.3 Da. From the SEC75 chromatogram, the MSL3 (2-91) chromodomain had a 
retention volume of 13.99 mL, which correlates to a molecular weight of 12691 Da. The D. 
melanogaster MSL3 (2-91) chromodomain is therefore likely to be homogenous in solution as a 
monomer. During the process of refining the purification process, it was observed that a 
reducing agent had to be present throughout, beginning at lysis. If a reducing agent was not 
present, oxidized MSL3 (2-91) oligomers were observed at the size exclusion stage, with 
retention volumes of 10.75 mL and 5.61 mL, indicative of their higher molecular weight than 
the monomer  (Figure 3.6). 
 
 
 
 
 
 
 
 
 
Figure 3.6: Size exclusion chromatography of oxidized D. melanogaster MSL3 (2-91) 
chromodomain. 500 µL was loaded onto a Superdex 75 column at a flow rate of 0.5 mL/min. 
Absorbance (280 nm) is shown in blue (mAU is absorbing units x 1000). 
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3.2.2 Limited Proteolysis 
In order to investigate the stability of the truncated D. melanogaster MSL3 
chromodomain (2-91), the purified protein was subjected to limited trypsin proteolysis (Figure 
3.7). At a molar ratio of 1:1000 trypsin to MSL3 (2-91) chromodomain, little proteolytic 
degradation was observed after an hour at room temperature. This indicated that the expressed 
domain was likely to be folded and stable. Significant proteolytic degradation was observed at a 
molar ratio of 1:100 trypsin to MSL3 (2-91) chromodomain. A molar ratio of 1:100 was chosen 
to demonstrate that the protease was active, as significant proteolysis would be expected at this 
ratio. 
 
3.2.3 Oligonucleotide Association with the D. melanogaster MSL3 
Chromodomain 
During the GST affinity purification, it was observed that the eluted fraction absorbed 
strongly at 260 nm when analyzed by UV spectroscopy, indicating the likely presence of an 
oligonucleotide (Figure 3.8 A). The species was able to be ethanol precipitated, stained with 
ethidium bromide when run on an agarose gel, and digested by RNAse A and Benzonase (an 
oligonuclease) (Figure 3.8 B). The strong absorption of the oligonucleotide at 260 nm meant 
that its presence prevented determination of the protein concentration by UV spectroscopy at 
280 nm, and prevented monitoring the elution of the protein from the ion exchange column by 
UV spectroscopy at 280 nm. To avoid these complications, benzonase was added to the lysate 
in subsequent purifications. 
 
3.2.4 Vapour Diffusion Crystallization Screens 
After ion exchange and SEC chromatography, the purified D. melanogaster MSL3 (2-
91) chromodomain was concentrated to 20 mg/mL and equilibrated into a buffer containing 20 
mM Bis-Tris-propane, pH 7, 50 mM NaCl, 5 mM TCEP. Crystallization conditions were 
initially investigated using the Emerald Biosciences Wizard I and II and Hampton Research 
Crystal Screen I and II commercial sparse matrix screens. Duplicate drops were set up, with 
protein alone and protein with a histone H4 N-terminal peptide at a 20 % molar excess. Both an 
unmodified H4 N-terminal peptide and an H4K16Ac peptide were used independently. No 
conditions were identified that yielded observable crystals. 
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Figure 3.7: Limited proteolysis of the D. melanogaster MSL3 chromodomain (2-91). SDS-
PAGE (17% acrylamide:bis [37.5:1])  of the limited proteolysis of the D. melanogaster MSL3 
chromodomain (2-91). 5 µL of 20 mg/mL MSL3 (2-91) was incubated with trypsin at a 1:1000 
molar ratio for 5, 10, 20, 40 and 60 minutes. A sample was also incubated at a molar ratio of 
1:100 for 60 mins (60*). 
 
A.                                                                                                             B. 
 
 
 
 
 
 
 
Figure 3.8: The D. melanogaster MSL3 chromodomain is likely to copurify with an 
oligonucleotide. A. After GST affinity purification, 1mL of the eluate was placed into a quartz 
cuvette and analyzed by UV spectroscopy, scanning absorption at wavelengths from 200 nm to 
300 nm. B. 5% Agarose gel of the ethanol precipitated species. The first two lanes are 
molecular size markers followed by an untreated sample (control [lane c]), RNAse A treated 
(lanes 1 and 2) and benzonase treated samples (lane 3). 
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3.2.5 Site-directed Mutagenesis 
In order to address the issue of the D. melanogaster MSL3 chromodomain forming 
oxidized cysteine oligomers, mutation of Cys66 was investigated (see section 2.3.16.2). Primers 
were designed for mutagenesis of the Cys residues to Ser, due to the conserved nature of the 
mutation.  
Two peaks were observed during cation exchange chromatography of the D. 
melanogaster MSL3 chromodomain (2-91) C66S mutant (Figure 3.9). Both peaks are MSL3 
(2-91) chromodomain, as determined by SDS-PAGE, indicating that the protein was still able to 
oxidize. It was concluded, based upon the C66S single mutation results, that keeping the protein 
in the presence of a reducing agent was more effective in preventing oxidation, than mutation 
of the Cys residues. 
 
 
 
 
 
Figure 3.9: Cation exchange chromatogram of the D. melanogaster MSL3 chromodomain (2-
91) mutant C66S. The mutant  chromodomain was loaded onto a SourceS cation exchange 
column at 1 mL/min. The protein was bound and washed with buffer A prior to a gradient 
elution with buffer B. Absorbance (280 nm) is shown in blue (mAU is absorbing units x 1000), 
conductivity (indicating salt concentration) in brown (mS/cm), and concentration (percentage of 
buffer B) is shown in green (%B). 
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3.3 Cloning and Purification of the H. sapiens MSL3 Chromodomain (2-93) 
The H. sapiens MSL3 (2-93) chromodomain construct was designed by Dr. S. Moore 
based upon sequence alignment with other known chromodomains, such as HP1 and Pc. Ewa 
Kerc (University of Saskatchewan) contributed to the cloning, ligation, transformation, and 
plasmid purification. The construct encodes a 92 amino acid domain with a theoretical pI and 
molecular weight of 9.72 and 10781.2 Da, respectively based upon the amino acid sequence. 
The H. sapiens MSL3 (2-93) chromodomain shares high sequence identity (46%) with its D. 
melanogaster orthologue (Figure 1.13). Purification of the H. sapiens MSL3 (2-93) 
chromodomain by GST affinity purification was effective in purifying the GST-MSL3 from the 
crude lysate. Only faint bands indicating remaining impurities were visible by SDS-PAGE. The 
GST-MSL3 ran at approximately 36 kDa, which was the expected size for the chimera (Figure 
3.10 A). The chimera appeared stable as no visible degradation products were observed by 
SDS-PAGE. When digested with PreScission protease, three major fragments were observed 
corresponding to GST-MSL3 (36 kDa), GST (25 kDa), and MSL3 (11 kDa), indicating that 
cleavage had not gone to completion (Figure 3.10 B). 
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C.                                                                                                                           D. 
 
E.                                                                                                                         F. 
 
 
 
Figure 3.10: Purification of the H. sapiens MSL3 (2-93) chromodomain. A. SDS-PAGE (17% 
acrylamide:bis [37.5:1]) of the eluted GST-MSL3 after GST affinity purification. Molecular 
weight markers are shown. B. SDS-PAGE of the GST-MSL3 after cleavage with PreScission 
protease. C. Cation exchange chromatogram of the MSL3 chromodomain. The cleaved MSL3 
chromodomain was loaded onto a SourceS cation exchange column at 1 mL/min. Absorbance 
(280 nm) is shown in blue (mAU is absorbing units x 1000), conductivity (indicating salt 
concentration) in brown (mS/cm), and concentration (percentage of buffer B) is shown in green 
(%B). D. SDS-PAGE of the peak eluted during cation exchange chromatography. E. Size 
exclusion chromatography of the MSL3 chromodomain. 500 µL was loaded onto a Superdex 75 
column at a flow rate of 0.5 mL/min. The eluate was collected in 1 mL fractions. F. SDS-PAGE 
of the peak that eluted from the SEC75 column. Molecular weight markers are shown. 
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After GST affinity purification and PreScission protease digestion, the MSL3 (2-93) 
chromodomain was purified to homogeneity by cation exchange and size exclusion 
chromatography (SEC) (Figure 3.10 C-F). The H. sapiens MSL3 (2-93) chromodomain had a 
retention volume of 14.31 mL, which corresponds to an experimentally determined molecular 
weight of 11145 Da. The H. sapiens MSL3 (2-93) chromodomain was therefore homogeneous 
in solution as a monomer, based upon SEC and SDS-PAGE. 
 After size exclusion chromatography, the MSL3 (2-93) chromodomain was 
concentrated to approximately 20 mg/mL in a total volume of 200 µL, a total yield of 
approximately 4 mg of protein from 2 L of culture. The concentration was calculated using 
Beer’s Law (Equation 3.1) and the solutions absorbance, measured at 280 nm. 
 
3.3.1 Limited Proteolysis of the H. sapiens MSL3 (2-93) Chromodomain 
In order to investigate the stability of the truncated H. sapiens MSL3 chromodomain (2-
93), the purified protein was subjected to limited trypsin proteolysis (Figure 3.11). At a molar 
ratio of 1:1000 trypsin to MSL3 (2-93), proteolytic degradation was observed after 5 min at 
room temperature. A stable fragment was observed after an hour (Figure 3.11).  
 
 
 
 
 
 
Figure 3.11: Limited proteolysis of the H. sapiens MSL3 chromodomain (2-93). hsMSL3 2-93 
was incubated with trypsin at a 1:1000 molar ratio for 5, 10, 20, 40 and 60 minutes. A sample 
was also incubated at a molar ratio of 1:100 for 60 mins (60*). 
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Proteolytic degradation was complete, at a molar ratio of 1:100 after 1 hr.  The 
conditions of the limited proteolysis experiment were identical to the proteolytic digestion of 
the D. melanogaster MSL3 (2-91) chromodomain. Comparison of the two indicated that the H. 
sapiens MSL3 (2-93) chromodomain was not likely to be as stable to trypsin digestion as its D. 
melanogaster counterpart. 
 
3.4 Purification and Crystallization Screening of the S. pombe SWI6 
Chromodomain (77-135) 
The S. pombe SWI6 (77-135) chromodomain was also cloned, expressed and purified, 
for use as a control in future binding studies. The S. pombe SWI6 (77-135) chromodomain is a 
close homologue of the D. melanogaster HP1 chromodomain, which is known to bind 
H3K9Me3 histone N-terminal tails (Lachner et al., 2001). 
The S. pombe SWI6 (77-135) chromodomain construct encodes a 59 amino acid domain 
with a theoretical pI and molecular weight (MW) of 4.58 and 6959.5 Da, respectively, based 
upon the amino acid sequence. Ewa Kerc (University of Saskatchewan) contributed to the 
cloning, ligation, transformation, and plasmid purification. 
Based upon SDS-PAGE, the GST affinity purification was effective in purifying the 
GST-SWI6 from the crude lysate, as no major other contaminants were observed. The GST-
SWI6 ran at a molecular weight of approximately 32 kDa, as expected (Figure 3.12 A). The 
SWI6 (77-135) chromodomain was purified to homogeneity by anion exchange and SEC 
(Figure 3.13 B-E). Anion exchange was chosen due to the low pI of the protein (4.58). 
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B.                                                                                                                            C. 
 
 
 
D.                                                                                                                              E 
 
 
 
 
Figure 3.12: Purification of the S. pombe SWI6 (77-135) chromodomain. A. SDS-PAGE (17% 
acrylamide:bis [37.5:1]) of the eluted GST-SWI6 after GST affinity purification. B. Anion 
exchange chromatogram of the SWI6 chromodomain. The cleaved SWI6 chromodomain was 
loaded onto a SourceQ anion exchange column at 1 mL/min. The protein was bound and 
washed with buffer A (see section 2.3.13.1) prior to a gradient elution with buffer B. 
Absorbance (280 nm) is shown in blue (mAU is absorbing units x 1000), conductivity 
(indicating salt concentration) in brown (mS/cm), and concentration (percentage of buffer B) is 
shown in green (%B). C. SDS-PAGE of the peak eluted during anion exchange 
chromatography. D. Size exclusion chromatography of the SWI6 chromodomain. 500 µL was 
loaded onto a Superdex 75 column at a flow rate of 0.5 mL/min. The eluate was collected in 1 
mL fractions. E. SDS-PAGE of the peak that eluted from the SEC75 column. 
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The SWI6 (77-135) chromodomain has a theoretical molecular weight of 6959 Da and 
an apparent molecular weight of 7 kDa, as determined by SDS-PAGE. The SWI6 (77-135) 
chromodomain eluted from the Superdex 75 column at a retention volume of 13.47 mL, which 
corresponded to a molecular weight of 15845 Da, calculated using the standard curve. This may 
indicate that the SWI6 (77-135) chromodomain is a dimer in solution. The purified SWI6 (77-
135) chromodomain was concentrated to approximately 20 mg/mL, in a total volume of 400 
µL, a total yield of approximately 8 mg of protein from 2 L of culture. 
 
3.4.1 Vapour Diffusion Crystallization Screens 
After ion exchange and SEC chromatography, the purified S. pombe SWI6 (77-135) 
chromodomain was concentrated to approximately 20 mg/mL using Millipore Amicon Ultra 5k 
Dalton cut-off centrifugal filter devices and equilibrated into a buffer containing 20 mM Bis-
Tris-propane, pH 7, 50 mM NaCl, 5 mM TCEP. Crystallization conditions were initially 
investigated using the Emerald Biosciences Wizard I and II and Hampton Research Crystal 
Screen I and II commercial sparse matrix screens. For each condition, two drops were set up, 
one with just the SWI6 chromodomain and one with the chromodomain and the H3K9Me3 
peptide, at a 20% molar excess. No conditions were identified that yielded observable crystals. 
 
3.5 D. melanogaster MOF Chromodomain (371-440) 
 
3.5.1 Cloning and Purification of the D. melanogaster MOF Chromodomain 
(371-440) 
The original D. melanogaster MOF chromodomain (371-440) construct was designed 
by Dr. S. Moore and cloned into the pGEX-6P3 expression vector by J. Guenther (University of 
Saskatchewan). The theoretical pI and molecular weight of the 70 amino acid MOF (371-440) 
chromodomain is 5.84 and 8098.8 Da, respectively. 
After GST affinity chromatography, the eluted GST D. melanogaster MOF (371-440) 
chromodomain was analyzed by SDS-PAGE; a large single band was observed at 
approximately 33 kDa. The GST affinity purification was effective in purifying the GST-MOF 
from the crude lysate as no other major bands were observed by SDS-PAGE (Figure 3.13 A). 
When digested with PreScission protease, two fragments were observed on the SDS-PAGE gel,
 77 
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E.                                                                                                                                 F. 
 
 
 
Figure 3.13: Purification of the D. melanogaster MOF chromodomain (371-440). A. SDS-
PAGE (17% acrylamide:bis [37.5:1]) of the eluted GST-MOF after GST affinity purification. 
Molecular weight markers are shown. B. SDS-PAGE of the GST-MOF after cleavage with 
PreScission protease. C. Cation exchange chromatogram of the MOF chromodomain. The 
cleaved MOF chromodomain was loaded onto a SourceS cation exchange column at 1 mL/min. 
The protein was bound and washed with buffer A (see section 2.3.13.1) prior to a gradient 
elution with buffer B. Absorbance (280 nm) is shown in blue (mAU is absorbing units x 1000), 
conductivity (indicating salt concentration) in brown (mS/cm), and concentration (percentage of 
buffer B) is shown in green (%B). D. SDS-PAGE of the MOF chromodomain after cation 
exchange chromatography. E. Size exclusion chromatography of the MOF chromodomain after 
cation exchange chromatography. 500 µL was loaded onto a Superdex 75 column at a flow rate 
of 0.5 mL/min. The eluate was collected in 1 mL fractions. F. SDS-PAGE of the peak that 
eluted from the SEC75 column. Molecular weight markers are shown. 
 
 
 
as expected, with molecular weights consistent with the MOF  (371-440) chromodomain (8 
kDa) and GST (25 kDa) (Figure 3.14 B). After removal of the cleaved GST and further 
purification by cation exchange chromatography and SEC, the D. melanogaster MOF 
chromodomain (371-440) was visibly homogenous, based upon SDS-PAGE (Figure 3.13 F). 
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The theoretical molecular weight of the D. melanogaster MOF (371-440) 
chromodomain is 8098.8 Da. From the SEC75 chromatogram, the MOF (371-440) 
chromodomain had a retention volume of 14.11 mL, which corresponded to a molecular weight 
of 12119 Da. The D. melanogaster MOF (371-440) chromodomain was therefore likely to be 
homogenous in solution as a monomer. 
The D. melanogaster MOF precipitated irreversibly when dialysed from elution buffer 
(pH 8.0) into a sodium acetate buffer (pH 5.0) for cation exchange, through its isoelectric point 
(pI 5.84). This was only partially abrogated by dialyzing in two steps, as previously described 
(section 2.3.14). The theoretical pI of the D, melanogaster MOF chromodomain (371-440), 
based upon the amino acid sequence is 5.84 (70 amino acids, MW 8098.8 Da). The D. 
melanogaster MOF chromodomain (371-440) was purified by anion exchange in a buffer 
containing 50 mM Tris.HCl, 5 mM DTT, pH 8.0 (buffer A) (Figure 3.14 A). No precipitation 
was observed during dialysis. The two peaks observed in the chromatogram are D. 
melanogaster MOF (371-440) chromodomain (left) and GST (right). The remaining GST is 
likely due to insufficient dialysis to remove the majority of the glutathione. Compared to the 
SEC75 chromatogram of the MOF (371-440) chromodomain purified by cation exchange, the 
SEC75 profile is unchanged, as expected (Figure 3.14 B). 
 
3.5.2 Vapour Diffusion Crystallization Screens 
After ion exchange and SEC chromatography, the purified D. melanogaster MOF 
chromodomain (371-440) was concentrated to approximately 20 mg/mL using Millipore 
Amicon Ultra 5k Dalton cut-off centrifugal filter devices and equilibrated into a buffer 
containing 20 mM Bis-Tris-propane, pH 7, 50 mM NaCl, 5mM TCEP. Crystallization 
conditions were initially investigated using the Emerald Biosciences Wizard I and II and 
Hampton Research Crystal Screen I and II commercial sparse matrix screens. Small crystals 
were observed in condition 16 (1.0 M sodium citrate, 100 mM CHES, pH 9.5) of the Wizard II 
screen. The crystals had a hexagonal column morphology, indicating a possible hexagonal or 
trigonal Bravais lattice (Figure 3.15). Sodium citrate concentration and pH were screened to 
optimize crystal size. Crystals of sufficient size (approximately 0.5 mm by 0.1 mm) for 
diffraction on the in-house Proteum Copper (Cu) rotating anode diffractometer were grown 
from 1 M sodium citrate, 100 mM CHES, pH 9.5, 15% glycerol (Figure 3.16). The inclusion of 
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glycerol meant that the crystals could be directly frozen in the mother liquor (the solution from 
which the crystals grew) without requiring transfer into a cryo-protectant. 
 
A. 
 
B. 
 
 
Figure 3.14: Anion exchange chromatography of the D. melanogaster MOF (371-440) 
chromodomain. A. The cleaved MOF chromodomain was loaded onto a SourceQ anion 
exchange column at 1 mL/min. The protein was bound and washed with buffer A (see section 
2.3.13.1) prior to a gradient elution with buffer B. Absorbance (280 nm) is shown in blue 
(mAU is absorbing units x 1000), conductivity (indicating salt concentration) in brown 
(mS/cm), and concentration (percentage of buffer B) is shown in green (%B). B. Size exclusion 
chromatography of the MOF chromodomain after pooling and concentration of the fractions 
from anion exchange. 500 µL was loaded onto a Superdex 75 column at a flow rate of 0.5 
mL/min. The eluate was collected in 1 mL fractions. 
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3.5.3 Data Collection and Data Processing of Native D. melanogaster MOF 
Chromodomain (371-440) Crystals 
Initial diffraction images and the first native data set were collected at the Saskatchewan 
Structural Sciences Centre using a DX8 Proteum Copper (Cu) rotating anode diffractometer 
with a Kappa goniostat and Proteum 4K charge-coupled device (CCD) detector. Crystals were 
diffracted under a stream of nitrogen at 114 K using a Kryoflex low temperature apparatus. The 
crystals diffracted well (Figure 3.16). Spots were discernible out to 1.9 Å resolution. Each 
image was collected over a 0.5° oscillation around omega over a 1 min period. A total of 600 
images, 300° of data were collected. The diffraction images were processed using SaintPlus and 
ProScale (Bruker AXS Inc).  The cell parameters and the statistics of the processed data are 
summarized in Tables 3.2 and 3.3, respectively. 
The unit cell was indexed and the cell parameters calculated. Based upon the cell 
volume (Vcell), using the Matthews coefficient equation, there are likely four or five molecules 
in the asymmetric unit of the primitive hexagonal lattice (Equation 3.3) (Matthews, 1968) 
(Figure 3.17). 
 
A.                                                             B. 
                  
 
 
Figure 3.15: Crystals of D. melanogaster MOF (371-440) chromodomain. A. A schematic 
diagram depicting the hexagonal Bravais lattice and the formula for calculating the unit cell 
volume. B. Crystals of D. melanogaster MOF (371-440) chromodomain, grown from 1 M 
sodium citrate, 100 mM CHES, pH 9.2, 15% glycerol. 
0.5mm 
Volume = a2c(sin[60o]) 
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Figure 3.16: Bruker Proteum CCD detector diffraction image of D. melanogaster MOF 
chromodomain crystals taken over a 0.5° oscillation for 1 min.  
 
 
Table 3.2: Summary of the native D. melanogaster MOF chromodomain crystals unit cell 
dimensions. The Bravais lattice is hexagonal and is either P61 or P65. 
 
    
Unit cell  
    
a 113.9 Å 
b 113.9 Å 
c 50.4 Å 
α 90o 
β 90o 
γ 120o 
    
  
Hexagonal P61 or P65 
Volume (Vcell) 566250 Å3 
Mosaicity 0.45o 
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Table 3.3: Summary of data processing for the native D. melanogaster MOF chromodomain 
(371-440) crystal data set. The resolution of each shell (Res. Shell), the number of observed 
reflections (nRef Obs), the number of expected reflections (nRef Exp), the completeness 
(Comp. %), redundancy (Redund), the difference between  multiple symmetry related 
reflections (Rsym), the R factor applied to a small subset of reflections that are not used in the 
refinement (Rfree), the measure of the reflections intensity compared to the background (I/sigI), 
and the statistical measure of the fit between the theoretical frequency distribution and the 
observed frequency distribution of the observed data (Chi2) are shown. 
 
 
                          
Res. nRef nRef Compl 
  Shell Obs Exp % Redund Rsym- shell Rfree nRfree I/sigI shell Chi2 
 37.88                
to 4.82 1898 1910 99.37 10.79 0.0343 0.0343 0.0381 86 20.51 20.51 1.11 
to 3.81 3809 3821 99.69 10.93 0.0365 0.038 0.0397 187 19.84 19.2 1.14 
to 3.32 5720 5738 99.69 10.97 0.0407 0.0517 0.0428 280 17.8 13.75 1.11 
to 3.01 7632 7651 99.75 10.83 0.0459 0.0767 0.0478 376 15.8 9.54 1.08 
to 2.79 9529 9551 99.77 10.57 0.0513 0.12 0.0535 464 14.06 6.08 1.04 
to 2.62 11451 11474 99.8 10.2 0.0564 0.174 0.0581 557 12.7 4.18 1 
to 2.49 13351 13380 99.78 9.54 0.0598 0.2104 0.0608 637 11.94 3.5 0.98 
to 2.38 15258 15287 99.81 8.87 0.0623 0.255 0.0635 732 11.41 2.9 0.95 
to 2.29 17181 17215 99.8 8.24 0.0641 0.2562 0.0661 838 11.03 2.71 0.93 
to 2.2 19096 19384 98.51 7.67 0.0655 0.2737 0.0674 912 10.74 2.39 0.91 
to 2.1 21017 22173 94.79 7.14 0.0664 0.332 0.0682 966 10.52 1.74 0.9 
                          
             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equation 3.3: Matthew’s coefficient (VM) equation. Z is the number of asymmetric units in the 
unit cell, N is the number of molecules in the asymmetric unit and Mw(Da) is the molecular 
weight of the molecule. 
 
Vcell 
  
Mw(Da)*Z*N 
Vm =  
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Figure 3.17: Matthews’s coefficient (VM) calculation for the D. melanogaster MOF 
chromodomain (371-440) native data set. The probability (blue) of the number of molecules in 
the asymmetric unit (red [X]) is plotted against the Matthews coefficient (Vm). Z is the number 
of asymmetric units in the unit cell (Matthews, 1968). 
 
 
3.5.4 Molecular Replacement. 
Molecular replacement was attempted to solve the D. melanogaster MOF 
chromodomain (371-440) crystal structure using the native data set, the D. melanogaster MOF 
chromodomain NMR structure (Nielsen et al., 2005) and the PHASER molecular replacement 
software (McCoy et al., 2007), as outlined in section 2.3.22.1. The solution structure protein 
data base file (2BUD) is an ensemble of 25 models. The whole or partial ensemble was used in 
PHASER to calculate structure factors with the full side-chain (Full) or the side-chain truncated 
to an Ala residue (Ala) with the exception of Gly. Analysis of the ensemble reveals large root-
mean-squared deviation of residues at the N- and C-terminus between models.  Therefore in all 
cases each model used in the respective ensemble was truncated to residues 378 to 443.  An 
ensemble was also prepared with the 402-410 loop excised due to large root-mean-squared 
deviation between models (Ala-loop). The PHASER results are summarized in Table 3.4. 
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Table 3.4: Summary of the molecular replacement results using PHASER (McCoy et al., 2007) 
and the D. melanogaster MOF chromodomain NMR structure (Nielsen et al., 2005). The search 
model ensemble either had the residue side chain (full) or was truncated to an Ala. The 
ensemble number is the number of models used to calculate the model structure factors. The 
resolution is the data used in the calculation and the search is the number of molecules searched 
for in the asymmetric unit. Log-likelihood gain (LLG) statistics and the Z-score (signal to 
noise) are shown for the initial and final fast rotation function (FRF) and fast translation (FTF) 
solutions. Eulerian angles were not consistent for each of the solution. 
 
 
                  
    
Initial 
Sol.    Final Sol.  
           
 Ensemble RESOLution Search FRF FTF   FRF FTF 
        LLG (Z)  LLG (Z)      LLG (Z)   LLG (Z)  
Full 25 4-8 2 
4.79 
(3.17) 
12.64 
(4.70) P65 
18.59 
(3.20) 
29.90 
(4.84) 
Full 1 4-8  2 
4.05 
(3.55) 
9.85 
(4.40) P61 
15.55 
(3.44) 
27.45 
(5.28) 
Full 23 6-15 2 
4.61 
(3.87) 
10.01 
(3.36) P65 
15.04 
(3.52) 
27.27 
(4.97) 
Full 23 6-10 4 
3.67 
(3.76) 
8.82 
(3.68) P65 
46.42 
(3.34) 
56.45 
(4.70) 
Full 23 6-37 1 
4.77 
(3.86) 
10.12 
(3.45) P61   
Full 23 6-37 2 
15.94 
(3.51) 
23.84 
(4.54) P61 
33.19 
(3.04) 
44.17 
(4.54) 
Ala-
loop 24 4-8 2 
4.46 
(3.82) 
9.98 
(3.79) P65 
16.18 
(4.03 
26.86 
(4.77) 
Ala-
loop 24 4-8 4 
4.46 
(3.82) 
9.98 
(3.79) P65 
54.34 
(3.37) 
66.02 
(4.68) 
Ala-
loop 24 6-37 3 
3.19 
(3.16) 
8.41 
(3.83) P61 
32.31 
(3.17) 
43.21 
(4.23) 
Ala-
loop 24 4-37 3 
6.41 
(3.87) 
14.51 
(4.44) P61 
48.55 
(4.12) 
59.51 
(4.83) 
Ala-
loop 24 4-10 3 
5.89 
(3.85) 
13.81 
(4.45) P65 
42.50 
(3.68) 
52.94 
(4.55) 
Ala-
loop 24 4-10 1 
3.14 
(3.88) 
8.38 
(4.66) P65   
Ala 25 3-15 4 
9.60 
(3.89) 
19.18 
(4.59) P65 
55.51 
(3.95) 
22.17 
(5.15) 
Full 6 4-8 4 
8.914 
(3.48) 
19.74 
(4.88) P61 
75.11 
(3.83) 
57.52 
(5.06) 
Full 6 4-8 2 
6.00 
(4.44) 
12.73 
(4.36) P61 
19.22 
(4.07) 
33.49 
(5.61) 
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The log-likelihood gain (LLG) statistics are very poor with no clear solution; the best 
solution had a LLG of 9.98 after the initial rotation and translation functions, increasing to only 
66.02 after the fourth molecule was fit. In comparison, the crystal structure of the Thrombin-
activable Fibrinolysis Inhibitor (TAFI), which has three molecules in the asymmetric unit had a 
LLG of 367 for the initial solution, and a LLG of 2047 for the third (Anand et al., 2008). 
 
3.5.5 Site-Directed Mutagenesis, Purification and Crystallization of Se-Met 
L423M Mutant D. melanogaster MOF Chromodomain (371-440) 
Failure of molecular replacement to find a solution using PHASER (McCoy et al., 
2007) and the solution structure of the D. melanogaster MOF chromodomain, solved by NMR 
(Nielsen et al., 2005)(PDB 2bud) meant that experimental techniques to measure the phases 
needed to be investigated. 
The D. melanogaster MOF chromodomain (371-440) construct does not contain any 
methionine residues. In order to incorporate seleno-methionine (Se-Met) into the MOF (371-
440) chromodomain to allow determination of phases by multi-wavelength anomalous 
dispersion (MAD), a methionine residue had to be introduced, via site-directed mutagenesis. A 
total of nine methionine mutants were cloned, expressed, and purified. Attempts to crystallize 
the purified I373M, L419M, and L423M D. melanogaster MOF chromodomain (371-440) 
mutants were made by screening sodium citrate concentration and pH around the conditions 
under which the wild-type protein crystallized. Results for each of the mutants is summarized in 
Table 3.5. 
The Se-Met MOF L423M mutant was purified under conditions similar to purification 
of the wild-type protein, using anion exchange chromatography to minimize the amount of 
protein lost to irreversible precipitation during dialysis. Overlay of the Se-Met MOF L423M 
mutant SEC75 profile with that of the L423M mutant and the wild-type protein revealed a small 
variation in the elution volume of the three proteins (Figure 3.18). A small variation in Ve is 
often observed, therefore the profiles of the three proteins are essentially identical. The Se-Met 
L423M MOF (371-440) crystals exhibited a hexagonal column morphology identical to the 
wild type crystals (Figure 3.19). 
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Table 3.5: Summary of each of the D. melanogaster MOF chromodomain (371-440) Met 
mutants. Only the L423M mutant was able to be crystallized under conditions close to the wild-
type protein. (-) indicates that the protein was not crystallized or that a Se-Met preparation was 
not carried out. 
 
         
Mutant Expressed 
 
Purified Crystallized Se-Met Prep. 
     
I373M yes yes - - 
I385M yes yes - - 
V397M yes yes - - 
V414M yes yes - - 
L419M yes yes - - 
L423M yes yes yes yes 
  V427M yes yes - - 
I432M yes yes - - 
L434M yes yes - - 
         
     
 
 
 
3.5.6 Data Collection and Data Processing of the Se-Met D. melanogaster 
MOF Chromodomain (371-440) L423M Crystals 
Initial diffraction images were collected at the Saskatchewan Structural Sciences Centre 
using a DX8 Proteum rotating Copper (Cu) anode diffractometer with a Kappa goniostat and 
Proteum 4K charge-coupled device (CCD) detector. Crystals were diffracted under a stream of 
nitrogen at 114 K using a Kryoflex low temperature apparatus. The crystals diffracted poorly 
(Figure 3.20). Diffraction was only discernible to approximately 3.3 Å. A total of 50 frames 
with a 0.5° oscillation around omega, over a 1 min period were collected. 
Fresh Se-Met D. melanogaster L423M MOF (371-440) chromodomain mutant protein 
was prepared and crystallized for diffraction experiments at the Canadian Light Source (CLS) 
on the Canadian Macromolecular Facility 1 (CMCF1) 08ID-1 beamline using a MAR225 
Detector. A selenium fluorescence scan was carried out to ascertain if Se-Met had been 
incorporated (Figure 3.21). Data was collected at the peak (12.6558 keV) and inflection 
(12.6553) points of the selenium absorption edge. 
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A. 
     
    
Protein Ve Kav MW 
     
    
Wild type 14.46 0.4097 10447.2 
L423M Met 13.97 0.3793 12852.9 
L423M Se-Met 14.19 0.3929 11721.9 
     
    
 
 
B. 
 
 
 
 
 
 
Figure 3.18: Comparison of the wild type (blue), L423M Met mutant (red), and L423M Se-Met 
mutant (green) D. melanogaster MOF (371-440) chromodomain SEC75 chromatograms. The 
respective retention volumes (Ve) and experimental molecular weights (MW) are shown (A), 
along with the SEC75 chromatograms of the three proteins (B). 
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Figure 3.19: Crystals of the Se-Met derivative of the D. melanogaster MOF chromodomain 
(371-440) L423M mutant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20: Comparison of the diffraction from wild type (left) and Se-Met derivative D. 
melanogaster MOF chromodomain (371-440) (right) crystals, taken over a 0.5° oscillation for 1 
min. The images were collected using DX8 Proteum rotating Copper (Cu) anode diffractometer 
with a Kappa goniostat and Proteum 4K charge-coupled device (CCD) detector. 
0.5mm 
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Diffraction of the crystals on the CMCF1 08ID-1 beamline was of much better quality 
than the diffraction from the DX8 Proteum rotating Copper (Cu) anode diffractometer. The 
diffraction images were processed using the HKL2000 (Otwinowski and Minor, 1997). 
Indexing of initial frames indicated that contrary to the earlier results, the Se-Met unit cell was 
in fact isomorphous to the wild type unit cell. The earlier result indicating that it was not 
isomorphous is likely due to a failure to index correctly due to the poor nature of the 
diffraction.  
A large number of crystals were mounted and diffracted. A large variation in the quality 
of diffraction was observed. A total of five Se-Met MAD data sets were collected. The data was 
systematically processed to optimize their relative statistics and the individual unmerged data 
sets compared. Processing results are summarized in Table 3.6.  
 
 
 
 
 
 
Figure 3.21: Fluorescence scan of the Se-K edge. A fluorescence scan at the Se-K edge of the 
Se-Met D. melanogaster MOF chromodomain (371-440) L423M crystals (blue) indicates Se-
Met incorporation. The real (f’) and imaginary (f”) components of the anomalous scattering 
factors are shown in red and green, respectively. 
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Based upon comparison of the processed data from the respective data sets, the Se_2 
data set (peak and inflection) was concluded to be of the highest quality, due to a Chi2 
approximately equal to one, the lowest Rsymm, highest resolution, and good completeness. It 
should be noted, however, that the redundancy was quite low (3.9). A high redundancy prevents 
erroneous rejection of a reflection (hkl) as an outlier. 
All the data sets collected were analyzed to ascertain the strength of the anomalous 
signal, which solution of the phase problem and subsequent resolution of the crystal structure 
relies upon. When Chi2 is plotted against resolution, Chi2 values greater than one and the 
exhibition of resolution dependence is a strong indicator of an anomalous signal whereas Chi2 
approximately equal to one and no resolution dependence indicates that there is no useful 
anomalous signal. The data sets collected all exhibit Chi2 close to one and showed little 
resolution dependency. Also, the Chi2 plot does not change if the Friedel pairs are treated as 
equivalent. To further analyze the quality of the anomalous signal, the SOLVE software 
(Terwilliger and Berendzen, 1999) was used to analyze the correlation of the anomalous signal 
between the peak and inflection data sets. SOLVE was run for all the Se data sets but the 
majority of the focus was on the Se_2 data set as this was determined to be of the highest 
quality. As a general guideline, data should be cut-off where the correlation drops below 0.3 
and a good data set should have an overall correlation of 0.7. The correlation on the anomalous 
signal between the peak and inflection indicated that the data should be cut-off around 3.3 Å 
(Table 3.7). 
The crystallographic software SOLVE (Terwilliger and Berendzen, 1999) was used to 
calculate the Patterson map and the derived position of the heavy atoms. Initial electron density 
maps were then calculated by SOLVE using the calculated phases for the heavy atoms. SOLVE 
analyses the non-randomness of the native Fourier map. Maps with distinct solvent regions 
typically have a high standard deviation (SD) of the local rms electron density (Terwilliger, 
2003). For the maps calculated using the Se_2 data, SOLVE reported a local rms of 0.25, which 
is not very high. Maps should also have a high correlation of local rms electron density at 
neighboring boxes. SOLVE reports a poor solution as having a local rms of 0.11. The 
calculated local rms for this solution was 9.55E-02. The overall Z score for the top solution 
found using SOLVE, which factors in the score from the native Fourier, the difference 
Patterson, the cross-validation Fourier, and the mean figure of merit was 9.22.
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Table 3.6: HKL2000 Results. The individual Se-Met MAD data sets were indexed, integrated, 
and scaled using HKL2000. Statistics for the scaled unmerged data sets are shown. Results for 
the Se_4 peak data set were calculated using 140 frames or (240) frames. 
 
 
              
 Se_2  Se_4  Se7  
 peak infl peak infl peak infl 
        
         
No. Frames 240 240 140 (240) 140 80 80 
Chi2 1.124 1.093 2.6 (4.696) 2.77 1.07 1.034 
Rsym (all hkl) 0.068 0.072 
0.078 
(0.116) 0.08 0.079 0.098 
Resolution (Å) 50-2.6 50-2.6 50-3 (50-3) 50-3 50-2.8 50-2.8 
Error scale factor 2.3 2.3 2.5 (2.5) 2.5 1.4 1.4 
Completeness  
(all hkl) 100 99.9 99.9 99.9 90.5 89 
Redundancy  
(all hkl) 3.9 3.9 4.4 (7.3) 4.4 5.4 5.1 
              
       
 
 
 
Table 3.7: Correlation coefficients in the anomalous signal between the peak and inflection 
data set for Se_2. 
    
  
Resolution 
Shell Correlation 
    
6 0.83 
4.5 0.71 
4.2 0.58 
3.98 0.55 
3.75 0.5 
3.6 0.43 
3.45 0.38 
3.3 0.28 
3.15 0.16 
3 0.23 
  
All 0.46 
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This was the highest Z score calculated for a solution from the five data sets. The algorithm in 
SOLVE for finding, evaluating and selecting heavy-atom solutions is iterative. SOLVE stops 
searching for solutions once a solution with a Z score above 10 has been identified (Terwilliger, 
2002). Using this solution, RESOLVE (Terwilliger, 2003) was run. RESOLVE is a density 
modification program that uses the calculated structure factors, the proteins amino acid 
sequence, and the expected characteristics of an electron density map of a macromolecule to 
modify the electron density maps calculated by SOLVE and build an initial model. Analysis of 
the maps and the model generated by RESOLVE indicated that a solution had not been found; 
the density was not continuous, nor was the model, and in many instances the small fragments 
that had been built into the density did not make any stereochemical or conformational sense. 
 
3.5.7 Data Collection and Data Processing of D. melanogaster MOF 
chromodomain Crystals Containing Br- or I- Anions. 
Several avenues to introduce either iodide or bromide anions were investigated. The 
methods investigated involved crystal soaking, co-crystallization, chemical modification, and 
vapour diffusion. The only method that worked was crystal soaking. Wild type crystals were 
rapidly transferred from the mother liquor into a solution containing 1.5 M sodium citrate, 100 
mM CHES pH 9.5, 0.5 M KI (or NaBr) before mounting and freezing under a stream of 
nitrogen at 114 K using a Kryoflex low temperature apparatus. 
Initial data was collected at the Saskatchewan Structural Sciences Centre using a DX8 
Proteum Copper (Cu) rotating anode diffractometer with a Kappa goniostat and Proteum 4K 
charge-coupled device (CCD) detector. Single isomorphous replacement (SIR), Single 
wavelength anomalous dispersion (SAD), and single isomorphous replacement with anomalous 
scattering (SIRAS) were all investigated using the in-house iodinated and native data sets. SIR 
involves calculation of the position and phases of the heavy atom by constructing a 
isomorphous differences Patterson map. The structure factor of the heavy atom derivative (FPH) 
is the vector sum of the heavy atom (FH) and the native protein atoms in the crystal (FP). 
Therefore a difference Patterson map can be calculated. SAD is a similar process, which 
constructs an anomalous differences Patterson map. SIRAS uses the combined isomorphous 
and anomalous data. Initial attempts at SIR gave very high R values, indicating that the two 
data sets were not indexed identically. In a hexagonal system, the definition of axes as a,b,c or 
b,a,-c are equally valid Figure 3.22 A). As a result, auto-indexing software may index using 
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either definition. Plotting the hk0 sections for the native and iodinated data indicated that this 
was the case in this instance (Figure 3.22 B), therefore the iodinated data was reindexed, 
changing the h,k,l to k,h,-l (Figure 3.22 C). 
A total of 300° of data was collected over 600 frames, each with an oscillation of 0.5° 
around omega over a 1 min period. The diffraction images were indexed and processed using 
SaintPlus and ProScale (Bruker AXS Inc). The unit cell is isomorphous to the native data set. 
Data processing statistics are summarized in Table 3.8. SIR, SAD, and SIRAS did not give a 
clear solution as to the location of the incorporated heavy atoms. 
 
 
Table 3.8: Summary of data processing for the iodinated D. melanogaster MOF chromodomain 
(371-440) crystal data set. 
 
 
                                
                
Res. 
Shell 
nRef 
Obs 
nRef 
Exp 
Compl 
% Redund Rsym Shell Rfree nRfree 
I/ 
sigI Shell Chi2 
AnoI/ 
SigI Shell 
N 
(I+) 
N 
(I-) 
                                
37.88                
to   
5.88 1060 1061 99.91 9.55 0.0665 0.0665 0.0678 51 9.97 9.97 0.99 6.51 6.51 5184 4935 
to   
4.63 2119 2120 99.95 9.78 0.0682 0.0695 0.0776 106 9.36 8.77 0.88 5.06 3.61 10644 10082 
to   
4.05 3172 3173 99.97 9.83 0.0703 0.0733 0.0757 155 9.22 8.95 0.91 4.61 3.71 16092 15095 
to   
3.66 4240 4241 99.98 9.87 0.0779 0.1012 0.0804 203 8.63 6.9 0.95 4.23 3.11 21633 20226 
to   
3.40 5293 5294 99.98 9.89 0.086 0.1326 0.0904 269 7.93 5.16 0.96 3.92 2.65 27090 25251 
to   
3.19 6365 6366 99.98 9.89 0.0937 0.1602 0.0972 314 7.28 4.06 0.94 3.66 2.41 32652 30291 
to   
3.03 7416 7417 99.99 9.77 0.1014 0.2113 0.1052 370 6.73 3.09 0.93 3.43 2.03 38118 34302 
to   
2.90 8492 8493 99.99 9.61 0.1096 0.2881 0.1112 415 6.23 2.21 0.92 3.23 1.86 43702 37870 
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Maps calculated with SOLVE had a low correlation of local rms electron density at 
neighboring boxes and poor overall Z scores. The maps did not display any continuous electron 
density and RESOLVE failed to build a recognizable model. Fragments that were built into the 
density were small and did not make any stereochemical or conformational sense. 
Further crystal soaking experiments were carried out in an attempt to collect better data 
at the Canadian Light Source (CLS) on the Canadian Macromolecular Facility 1 (CMCF1) 
08ID-1 beamline. However, the procedure used for soaking the crystals is highly damaging to 
the crystals, based upon comparison of the diffraction. Data collected was not of high quality. A 
summary of the data collected is shown in Table 3.9. 
 
 
Table 3.9: Summary of crystal soaking data. Br1, Br3, Br4, Br5 and Br6 refer to the separate 
data sets collected on different crystals, soaked in the Br- solution. Inflection data sets were not 
collected for Br1, Br4, Br5, and Br6 as the peak data set was of poor quality. 
 
 
 
       
 Br1 Br3  Br4 Br5 Br6 
 peak peak infl peak peak peak 
       
       
No. Frames 90 150 150 120 120 120 
Chi2 (all hkl) 6.2 1.261 1.304 1.495 7.419 3.055 
Rsym (all hkl) 0.107 0.11 0.101 0.1 0.165 0.145 
Resolution 
(Å) 50-3.0 50-3.0 50-3.0 50-3.0 50-4.14 50-2.17 
Completeness 
(all hkl) 97 99.9 99.9 99.8 99.6 75.7 
Redundancy 
(all hkl) 5.8 4.9 4.9 7.4 7.3 5.8 
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A. 
 
B. 
 
C. 
 
 
 
Figure 3.22: Reindexing of the iodinated derivative data. A. The two axes hkl and k,h,-l are 
related by rotating k onto h. In a hexagonal system they are equivalent. B. hk0 section for the 
native and derivative data showing that they are not indexed identically. C. hk0 section for the 
native and derivative data after the derivative data has been reindexed. 
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3.6 Cloning and Purification of the H. sapiens MOF Chromodomain (21-93) 
The H. sapiens MOF (21-93) chromodomain has a theoretical pI and molecular weight 
of 5.31 and 8595.5 Da, respectively. When the eluted H. sapiens MOF (21-93) chromodomain 
was analyzed by SDS-PAGE (17% acrylamide:bis [37.5:1]) after GST affinity chromatography 
a large single band was observed at approximately 33 kDa, indicating that the construct 
expressed well. The GST affinity purification was effective in purifying the GST-MOF from 
the crude lysate as no other major bands were observed by SDS-PAGE (Figure 3.23 A). When 
digested with PreScission protease, two fragments are observed on the SDS-PAGE gel, as 
expected, with molecular weights consistent with the MOF  (21-93) chromodomain (8 kDa) and 
GST (25 kDa) (Figure 3.23 B). After removal of the cleaved GST, the protein was further 
purified by anion exchange chromatography. Anion exchange was chosen due to the low pI of 
the protein (5.31). After anion exchange chromatography and SEC, the H. sapiens MOF 
chromodomain (21-93) was visibly homogenous, based upon SDS-PAGE  (Figure 3.24 D). The 
MOF (21-93) chromodomain has a theoretical molecular weight of 8595.5 Da and had an 
apparent molecular weight of between 6 and 14 kDa, as determined by SDS-PAGE (17% 
acrylamide:bis [37.5:1]). The MOF (23-91) chromodomain eluted from the Superdex 75 
column at a retention volume of 13.65 mL, which corresponds to a molecular weight of 14694 
Da. The difference between the theoretical molecular weight (8595.5 Da) and the size of the 
protein eluting from the Superdex 75 column was significantly different. This may indicate that 
the MOF (23-91) chromodomain is a dimer in solution. The purified MOF (23-91) 
chromodomain was concentrated to approximately 18 mg/mL, in a total volume of 200 µL, for 
a total yield of approximately 3.6 mg of protein from 2 L of culture. 
 
3.6.1 Vapour Diffusion Crystallization Screens 
After concentrating, the MOF (23-91) was equilibrated into a buffer containing 20 mM 
Bis-Tris-propane, pH 7, 50 mM NaCl, 5 mM TCEP. Crystallization conditions were initially 
investigated using the Emerald Biosciences Wizard I and II and Hampton Research Index, 
PEG/Ion and Crystal Screen I and II commercial sparse matrix screens. Further crystal screens 
were set up screening pH versus sodium/potassium phosphate, lithium sulfate, or ammonium 
sulfate based upon precipitate observed in similar conditions from the commercial screens. No 
conditions were identified that yielded observable crystals. 
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A.                                                                                                B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C.                                                                                                                                        D. 
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E. 
 
 
 
Figure 3.23: Purification of the H. sapiens MOF chromodomain (21-93). A. SDS-PAGE (17% 
acrylamide:bis [37.5:1]) of the eluted GST-MOF after GST affinity purification. Molecular 
weight markers are shown. B. SDS-PAGE (17% acrylamide:bis [37.5:1]) of the GST-MOF 
after cleavage with PreScission protease. Molecular weight markers are shown. C. Anion 
exchange chromatogram of the MOF chromodomain. The cleaved MOF chromodomain was 
loaded onto a SourceS cation exchange column at 1 mL/min. The protein was bound and 
washed with buffer A (see section 2.3.13.1) prior to a gradient elution with buffer B. 
Absorbance (280 nm) is shown in blue (mAU is absorbing units x 1000), conductivity 
(indicating salt concentration) in brown (mS/cm), and concentration (percentage of buffer B) is 
shown in green (%B). D. SDS-PAGE (17% acrylamide:bis [37.5:1]) of the eluted MOF 
chromodomain peak, collected in 1 mL. E. Size exclusion chromatography of the MOF 
chromodomain after pooling and concentration of the fractions from cation exchange. 500 µL 
was loaded onto a Superdex 75 column at a flow rate of 0.5 mL/min. The eluate was collected 
in 1 mL fractions.  
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4.0 Discussion 
 
4.1 Chromodomains of the D. melanogaster Dosage Compensation Complex 
At the outset of this research the precise functions of the MSL3 and MOF 
chromodomains were unknown. Since then, the MSL3 chromodomain has been reported to 
bind methylated H3K36Me3 (Larschan et al., 2007; Sural et al., 2008). It is suggested that 
recognition of the H3K36Me3 epigenetic mark is required for targeting and spreading of the 
DCC, in cis from the high affinity entry sites (Larschan et al., 2007; Sural et al., 2008). 
Corroborating this finding, the chromodomains of S. cerevisiae Eaf3 and H. sapiens MRG15, 
paralogues of the D. melanogaster MSL3 chromodomain, have also been demonstrated to bind 
H3K36Me3 (Sun et al., 2008; Zhang et al., 2006). It was noted during initial attempts to purify 
the D. melanogaster MSL3 chromodomain (2-96) that the domain copurified with a nucleic 
acid. This conclusion was based upon the copurification of a species that was not visible on an 
SDS-PAGE gel stained with Coomassie Blue but was able to be ethanol precipitated, and 
stained with ethidium bromide when run on an agarose gel. Interaction of the MSL3 
chromodomain with an oligonucleotide is in agreement with the findings by Akhtar, et al. 
(2000), who were the first to suggest that the MSL3 chromodomain binds roX RNA. The D. 
melanogaster dosage compensation complex contains two non-translated RNA molecules, 
roX1 and roX2. The notion that the MSL3 chromodomain (2-91) is sufficient for binding an 
oligonucleotide directly conflicts with previous findings that RNA binding is localized to 
residues 140-259 (Morales et al., 2005). Buscaino et al. (2006) suggest that the chromodomain 
and the polar region (140-259) act cooperatively to bind DNA. They demonstrated via 
electromobility shift assays that deletion of the chromodomain abrogated the ability of MSL3 to 
bind to DNA and mononucleosomes. Furthermore, they demonstrated that the chromodomain 
alone is able to bind to DNA and mononucleosome, but with reduced efficiently (Buscaino et al., 
2006). It is likely that the D. melanogaster MSL3 chromodomain binds H3K36Me3, and is 
involved in nucleotide binding. The MSL3 chromodomain is likely to play a key role in 
recruitment of MSL3 to the X chromosome (Buscaino et al., 2006; Larschan et al., 2007). 
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4.2 D. melanogaster MOF Chromodomain 
 
4.2.1 Molecular Replacement: PHASER 
The identification of conditions under which the D. melanogaster MOF chromodomain 
(371-440) reproducibly crystallized and the subsequent high quality of the diffraction data led 
to initial optimism that the solution of the crystal structure by molecular replacement using the 
D. melanogaster MOF chromodomain (367-454) NMR structure (Nielsen et al., 2005) would 
be relatively straight forward. However, the case proved problematic and the structure remains 
unsolved. This is likely due to the inherent problems of NMR models, the number of molecules 
in the asymmetric unit, the presence of non-crystallographic symmetry between monomers in 
the asymmetric unit, and the fact that the crystals have a hexagonal Bravais lattice. Each point 
is discussed below.  
Molecular replacement relies upon strong structural similarity between the target 
structure and the search model. The use of an NMR structure in the solution of a crystal 
structure by molecular replacement was first demonstrated in 1987 (Brunger et al., 1987). 
While molecular replacement using NMR-derived atomic coordinates is possible, it is generally 
problematic because NMR structures inherently are based upon short distance restraints and 
have a low observation to parameter ratio. There is also difficulty in representing the relative 
reliability of atomic positions in an NMR model. Crystallographic models include B factor 
information, which applies weights to the relative atomic contribution of the scattering factors. 
NMR ensembles are used by PHASER to reflect the precision of atomic positions. The 
imprecision and lack of long distance restraints allows for the introduction of errors into an 
NMR structure, which may manifest as relatively large rms differences between an NMR and 
crystallographic model that share 100% sequence identity. The greater the structural difference 
between the search model and the target structure, the less likely molecular replacement will be 
successful. The quality of the search model can be improved by judicious editing of the atomic 
coordinates. In this case, the conformers of the ensemble were compared. Regions that showed 
variation were deleted and side chains that were disordered were truncated to the Cβ atom 
(Ala). It is also possible that the D. melanogaster MOF chromodomain NMR structure deviates 
significantly from the crystal structure, preventing solution of the rotation and translation 
function.  
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The asymmetric unit is the smallest part of a crystal to which crystallographic symmetry 
may be applied to generate the unit cell (Figure 4.1). The asymmetric unit may be a single 
molecule or multiple molecules, in the case of proteins. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Graphical representation of the asymmetric unit, the unit cell, and the crystal 
structure and how they are related. In this instance the two asymmetric units in the unit cell are 
related by a two-fold rotation perpendicular to the plane of the page. 
 
 
Molecular replacement calculates phases from the search model after it has been 
correctly positioned into the asymmetric unit. The rotation and translation functions applied to 
the search model are calculated by measuring the agreement between the calculated and 
observed Patterson functions, which are derived from the calculated and observed structure 
factor amplitudes. Solution of a crystal structure by molecular replacement becomes 
increasingly more difficult as the number of molecules in the asymmetric unit increases because 
the relative scattering contribution of a single molecule becomes smaller i.e. the signal to noise 
ratio decreases. In this instance, based upon the Matthew’s coefficient (Matthews, 1968) there 
are probably 4 or 5 molecules in the asymmetric unit, therefore the relative scattering 
contribution of a single molecule is low and the signal that molecular replacement is searching 
for is small. This is further confounded by the crystals having a hexagonal Bravais lattice, as 
PHASER is searching six asymmetric units, compared to just one in the case of a monoclinic 
unit cell. A hexagonal Bravais lattice therefore further reduces the signal to noise ratio. High 
                                        Asymmetric Unit                                Unit Cell                                                   Crystal 
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non-crystallographic symmetry between molecules in the asymmetric unit, which is likely in 
this case further reduces the signal to noise ratio, making the translation search more difficult. 
PHASER uses a tree search with a pruning method. In the instance of searching for multiple 
molecules in the asymmetric unit, this involves using placement of first molecule as a 
background for searching for the second molecule and so on. This effectively increases the 
signal to noise ratio for the second search. Therefore the relative score of the solution should 
increase drastically as more molecules are placed into the asymmetric unit. Poor solutions are 
pruned out of the search. The success of this method relies upon the top rotation and translation 
functions of the initial search. For the case of molecular replacement of the D. melanogaster 
MOF chromodomain, the number of molecules searched for varied up to four molecules. The 
relative scores for the initial solution were very low and none improved drastically when the 
second, third, and fourth molecules were placed. In numerous occasions, solutions with the 
highest values were rejected due to excessive intermolecular contacts. 
In summary, failure of molecular replacement to solve the crystal structure of the D. 
melanogaster MOF chromodomain (371-440) is likely to be a combination of using an NMR 
model as the search model, the high number of molecules in the asymmetric unit, high non-
crystallographic symmetry, and a hexagonal Bravais lattice. 
 
4.2.2 Se-Met Incorporation and MAD 
The high pH and sodium citrate (a bidentate chelater) concentration meant that the 
soaking of a heavy metal into the crystal was not possible due to irreversible precipitation. In 
order to introduce selenium as the anomalous scatterer via Se-Met incorporation, a Met residue 
first had to be mutated into the sequence as none existed in the wild type D. melanogaster MOF 
chromodomain sequence (371-440). A total of nine mutants were made, of which only one 
crystallized, near wild type conditions. This may be due to Met incorporation preventing 
intermolecular contacts essential to crystallization. The D. melanogaster MOF chromodomain 
is very small and therefore Met incorporation is highly likely to alter the surface properties of 
the protein. The D. melanogaster MOF chromodomain (371-440) L423M mutant crystallized 
near wild type conditions and the crystal morphology was identical to the wild type protein 
crystals. It was noted that the crystals took one to two days longer to crystallize. The crystal 
initially had a undefined globular morphology with the distinct edges of the hexagonal prism 
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morphology resolving over approximately twenty-four hours. Neither the Met nor Se-Met 
version of the D. melanogaster MOF chromodomain (371-440) L423M mutant crystals 
diffracted as well as the wild type. The overall quality of the Se-Met derivative D. 
melanogaster MOF chromodomain (371-440) L423M mutant crystals diffraction was poor. 
While X-ray fluorescence scans confirmed the presence of Se-Met in the derivative crystal and 
an anomalous scattering signal was detected, it was not of high enough quality to solve the 
crystal structure by MAD. The poor anomalous signal could be due to a combination of the 
oxidation of the Se atoms, either during purification or diffraction, and/or disorder of the Se-
Met residue in the crystal lattice, and/or the relative placement of the Se atom in the unit cell. 
Little can be done if the Se-Met residue is disordered. In order to reduce the likelihood of 
oxidation, purification of the Se-Met derivative crystal was carried out as fast as possible in the 
constant presence of a reducing agent. In order to reduce the likelihood of the crystals 
becoming damaged during diffraction the beam was attenuated and the diffraction experiment 
optimized to minimize the exposure of the crystal. 
 
4.2.3 Iodide Incorporation and SIR 
Parallel to the Se-Met MAD attempt, experiments were conducted to incorporate iodide 
(I-) or bromide (Br-) ions into the crystal lattice by crystal soaking. Soaking involved the rapid 
transfer of the crystal from its mother liquor into a buffer containing KI or NaBr. Initially 
experiments saw the crystals visibly crack and dissolve within seconds of transfer. This is likely 
due to the salting-in effect of the salt, increasing the solubility of the protein. To overcome this, 
the sodium citrate concentration and the pH in the soaking buffer had to be increased to 
sufficiently decrease the solubility of the protein, preventing cracking and dissolving. Based 
upon diffraction of the soaked crystals, the soaking was still likely to be damaging. A large 
peak at the Br- absorption edge in the X-ray fluorescence spectrum, collected at the CLS 
confirmed incorporation of the halide, the data was poor and was likely not of sufficient quality 
to solve the crystal structure. The data was poor due to the likely damage of the crystal caused 
by soaking. Physical movement and soaking of the crystal along with incorporation of the 
halide ions could be interrupting crystal contacts causing large defects in the crystal lattice, 
which ultimately caused poor diffraction. Attempts to co-crystallize the protein in the presence 
of KI or NaBr also likely failed due to the salting-in effect on the protein. 
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4.3 Future Directions 
The research presented outlines the cloning, expression and purification of the D. 
melanogaster MOF and MSL3 chromodomains and their H. sapiens orthologues, along with 
the S. pombe SWI6 chromodomain. 
Crystallization conditions have been determined for the native D. melanogaster MOF 
(371-440) chromodomain. Future work will focus on crystallizing an isomorphous derivative 
containing a heavy atom, and collection of data of sufficient quality to allow for solution of the 
D. melanogaster MOF chromodomain crystal structure. Crystallization conditions for the other 
three constructs can also be investigated. Parallel to solving the crystal structure of the D. 
melanogaster MOF chromodomain, the molecular target needs also to be investigated to shed 
light on the role of the MOF chromodomain in the D. melanogaster dosage compensation 
complex. Binding studies between recombinant D. melanogaster MOF chromodomain and 
peptides representative of post-translationally modified histone tails could involve surface 
plasmon resonance, isothermal calorimetry, tryptophan fluorescence, and NMR techniques. 
These techniques can also be applied to structural and binding studies of the H. sapiens MOF 
and MSL3, S. pombe SWI6, and the D. melanogaster MSL3 chromodomain. 
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